US20160135888A1 - Systems, apparatus, methods and procedures for the noninvasive treatment of tissue using microwave energy - Google Patents

Systems, apparatus, methods and procedures for the noninvasive treatment of tissue using microwave energy Download PDF

Info

Publication number
US20160135888A1
US20160135888A1 US15/005,892 US201615005892A US2016135888A1 US 20160135888 A1 US20160135888 A1 US 20160135888A1 US 201615005892 A US201615005892 A US 201615005892A US 2016135888 A1 US2016135888 A1 US 2016135888A1
Authority
US
United States
Prior art keywords
tissue
antenna
energy
waveguide antenna
applicator
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US15/005,892
Inventor
Steven W. Kim
Daniel E. Francis
Jessi Ernest Johnson
Alexey Salamini
Ted Y. SU
Donghoon CHUN
Yoav Ben-Haim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Miradry Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2008/060929 external-priority patent/WO2009075904A1/en
Priority claimed from PCT/US2008/060935 external-priority patent/WO2008131302A2/en
Priority claimed from PCT/US2008/060922 external-priority patent/WO2009075903A1/en
Priority claimed from PCT/US2008/060940 external-priority patent/WO2008131306A1/en
Priority claimed from PCT/US2008/013650 external-priority patent/WO2009075879A1/en
Application filed by Individual filed Critical Individual
Priority to US15/005,892 priority Critical patent/US20160135888A1/en
Publication of US20160135888A1 publication Critical patent/US20160135888A1/en
Assigned to MIRAMAR LABS, INC. reassignment MIRAMAR LABS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: SALAMINI, ALEXEY, BEN-HAIM, YOAV, FRANCIS, DANIEL E., CHUN, Donghoon, JOHNSON, JESSI ERNEST, SU, TED Y., KIM, STEVEN W.
Assigned to OXFORD FINANCE LLC reassignment OXFORD FINANCE LLC SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: MIRAMAR TECHNOLOGIES, INC.
Assigned to MIDCAP FINANCIAL TRUST, AS AGENT reassignment MIDCAP FINANCIAL TRUST, AS AGENT SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: MIRAMAR LABS, INC., SIENTRA, INC.
Assigned to MIDCAP FINANCIAL TRUST, AS AGENT reassignment MIDCAP FINANCIAL TRUST, AS AGENT SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: MIRAMAR LABS, INC., SIENTRA, INC.
Assigned to MIRAMAR TECHNOLOGIES, INC. F/K/A MIRAMAR LABS, INC. reassignment MIRAMAR TECHNOLOGIES, INC. F/K/A MIRAMAR LABS, INC. RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS). Assignors: OXFORD FINANCE LLC
Assigned to MIRADRY, INC. reassignment MIRADRY, INC. CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: MIRAMAR TECHNOLOGIES, INC.
Assigned to MIRAMAR TECHNOLOGIES, INC. reassignment MIRAMAR TECHNOLOGIES, INC. CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: MIRAMAR LABS, INC.
Assigned to MIDCAP FUNDING IV TRUST, SUCCESSOR AGENT reassignment MIDCAP FUNDING IV TRUST, SUCCESSOR AGENT SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: MIDCAP FUNDING X TRUST (AS SUCCESSOR TO MIDCAP FINANCIAL TRUST)
Assigned to MIDCAP FINANCIAL TRUST, AS AGENT reassignment MIDCAP FINANCIAL TRUST, AS AGENT SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: MIRADRY HOLDINGS, INC., MIRADRY INTERNATIONAL, INC., MIRADRY, INC, SIENTRA, INC
Assigned to MIDCAP FINANCIAL TRUST, AS AGENT reassignment MIDCAP FINANCIAL TRUST, AS AGENT SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: MIRADRY HOLDINGS, INC., MIRADRY INTERNATIONAL, INC., MIRADRY, INC, SIENTRA, INC
Assigned to MIRADRY INTERNATIONAL, INC., MIRADRY HOLDINGS, INC., MIRADRY, INC. reassignment MIRADRY INTERNATIONAL, INC. RELEASE OF SECURITY INTEREST (REVOLVING) Assignors: MIDCAP FUNDING IV TRUST
Assigned to MIRADRY HOLDINGS, INC., MIRADRY, INC., MIRADRY INTERNATIONAL, INC. reassignment MIRADRY HOLDINGS, INC. RELEASE OF SECURITY INTEREST (TERM) Assignors: MIDCAP FINANCIAL TRUST
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/18Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves
    • A61B18/1815Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by applying electromagnetic radiation, e.g. microwaves using microwaves
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/02Radiation therapy using microwaves
    • A61N5/04Radiators for near-field treatment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00017Electrical control of surgical instruments
    • A61B2017/00022Sensing or detecting at the treatment site
    • A61B2017/00106Sensing or detecting at the treatment site ultrasonic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00005Cooling or heating of the probe or tissue immediately surrounding the probe
    • A61B2018/00011Cooling or heating of the probe or tissue immediately surrounding the probe with fluids
    • A61B2018/00023Cooling or heating of the probe or tissue immediately surrounding the probe with fluids closed, i.e. without wound contact by the fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00053Mechanical features of the instrument of device
    • A61B2018/00273Anchoring means for temporary attachment of a device to tissue
    • A61B2018/00291Anchoring means for temporary attachment of a device to tissue using suction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00315Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
    • A61B2018/00452Skin

Definitions

  • the present application relates to methods, apparatuses and systems for non-invasive delivery of energy, including microwave therapy.
  • the present application relates to methods, apparatuses and systems for non-invasively delivering energy, such as, for example, microwave energy, to the epidermal, dermal and sub-dermal tissue of a patient to achieve various therapeutic and/or aesthetic results.
  • energy-based therapies can be applied to tissue throughout the body to achieve numerous therapeutic and/or aesthetic results. There remains a continual need to improve on the effectiveness of these energy-based therapies and provide enhanced therapeutic results with minimal adverse side effects or discomfort.
  • FIG. 1 is an illustration of a system including a generator, applicator and disposable according to an embodiment of the invention.
  • FIG. 2 is a perspective view of a medical treatment device, including an applicator and disposable, according to an embodiment of the invention.
  • FIG. 3 is an end on view of the distal end of a medical treatment device, including an applicator and the disposable according to an embodiment of the invention.
  • FIG. 4 is an exploded perspective view of a medical treatment device according to an embodiment of the invention.
  • FIG. 5 is a view of a medical treatment device according to an embodiment of the invention including a cutaway view of applicator according to an embodiment of the invention.
  • FIG. 6 is a perspective view of a disposable according to an embodiment of the invention.
  • FIG. 7 is a view of a proximal side of a disposable according to an embodiment of the invention.
  • FIG. 8 is a side view of one end of a disposable according to an embodiment of the invention.
  • FIG. 9 is a side view of one end of a disposable according to an embodiment of the invention.
  • FIG. 10 is a view of a distal side of a disposable according to an embodiment of the invention.
  • FIG. 11 is a side view of a disposable according to an embodiment of the invention.
  • FIG. 12 is a cutaway side view of a disposable according to an embodiment of the invention.
  • FIG. 13 is a cutaway side view of a disposable according to an embodiment of the invention.
  • FIG. 14 is a cutaway perspective view of a disposable according to an embodiment of the invention.
  • FIG. 15 is a top perspective view of a proximal end of a disposable according to an embodiment of the invention.
  • FIG. 16 is a perspective view of an antenna array according to an embodiment of the invention.
  • FIG. 17 is an end view of a portion of an antenna array according to an embodiment of the invention.
  • FIG. 18 is a cutaway side view of a portion antenna array according to an embodiment of the invention.
  • FIG. 19 is a cutaway side view of a portion antenna array according to an embodiment of the invention.
  • FIG. 20 is a simplified cutaway view of a medical treatment device with tissue engaged according to an embodiment of the invention.
  • FIG. 21 is a simplified cutaway view of a medical treatment device with tissue engaged according to an embodiment of the invention.
  • FIG. 22 is a simplified cutaway view of a medical treatment device with tissue engaged according to an embodiment of the invention.
  • FIG. 23 is a graphical illustration of a pattern of lesions in tissue according to an embodiment of the invention.
  • FIG. 24 illustrates a treatment template according to an embodiment of the invention.
  • FIG. 1 is an illustration of a system 2309 including a generator 2301 , applicator 2320 (which may also be referred to as re-usable) and disposable 2363 according to an embodiment of the invention.
  • applicator 2320 and disposable 2363 may comprise a medical treatment device 2300 .
  • generator 2301 may operate in the ISM band of 5.775 to 5.825 GHz.
  • generator 2301 may have a Frequency centered at approximately 5.8 GHz.
  • generator 2301 includes circuitry for setting and controlling output power; measuring forward and reverse power and setting alarms.
  • generator 2301 may have a power output of between approximately 40 Watts and approximately 100 Watts.
  • generator 2301 may have a power output of between approximately 40 Watts and approximately 100 Watts where said output is measured into a 50 ohm load. According to an embodiment of the invention generator 2301 may have a power output of approximately 55 Watts measured into a 50 ohm load.
  • disposable 2363 and applicator 2320 may be formed into two separable units. According to an embodiment of the invention disposable 2363 and applicator 2320 may be formed into a single unit. According to an embodiment of the invention when combined disposable 2363 and applicator 2320 may form a medical treatment device 2300 .
  • generator 2301 may be a microwave generator.
  • applicator 2320 may be connected to generator 2301 by applicator cable 2334 .
  • applicator cable 2334 may include coolant conduit 2324 , energy cable 2322 , coolant thermocouple wires 2331 , cooling plate thermocouple wires 2330 and antenna switch signal 2481 .
  • coolant conduit 2324 may be connected to a coolant source 2310 (which may be, for example, a Nanotherm industrial recirculation chiller with 8 pounds per square inch pump output pressure available from ThermoTek, Inc.).
  • energy cable 2322 may be connected to generator 2301 by microwave output connector 2443 .
  • antenna switch signal 2481 may be connected to generator 2301 by antenna switch connector 2480 .
  • disposable 2363 may be connected to generator 2301 by vacuum tubing 2319 which may include generator bio-barrier 2317 , which may be, for example, a hydrophobic filter.
  • vacuum tubing 2319 may be connected to generator 2301 by vacuum port connector 2484 .
  • front panel 2305 of generator 2301 may include power control knob 2454 , vacuum control knob 2456 , antenna select switch 2462 (which may include both display elements and selection switches), vacuum meter 2486 , antenna temperature display 2458 , coolant temperature display 2460 , pre-cool timer 2468 (which may include both display elements and time set elements), energy timer 2470 (which may include both display elements and time set elements), post-cool timer 2472 (which may include both display elements and time set elements), start button 2464 , stop button 2466 , ready indicator 2476 and fault indicator 2474 .
  • vacuum tube 2319 may include a flexible vacuum hose 2329 and a generator bio-barrier 2317 .
  • flexible vacuum hose 2329 is adapted to collect fluids, such as, for example sweat or blood, which may escape disposable 2363 so that such fluids do not reach generator 2301 .
  • generator bio-barrier 2317 may include a hydrophobic filter to keep fluids out of vacuum port connector 2484 of generator 2301 .
  • generator bio-barrier 2317 may include a hydrophobic filter, such as, for example, a Millex FH Filter made of 0.45 micrometer hydrophobic PTFE which is available from Milipore.
  • generator bio-barrier 2317 may be positioned in vacuum tube 2319 between flexible vacuum hose 2329 and vacuum port connector 2484 .
  • applicator cable 2334 may connect generator 2301 to applicator 2320 .
  • cooling plate thermocouple wires 2330 and coolant thermocouple wires 2331 may be connected to generator 2301 by temperature connector 2482 .
  • coolant conduit 2324 may convey cooling fluid from a coolant source 2310 to applicator 2320 .
  • applicator cable 2334 may convey microwave switch selection data to applicator 2320 and temperature data from thermocouples in applicator 2320 to generator 2301 .
  • applicator cable 2334 may comprise one or more separate cables and connectors.
  • a generator connector may be designed and adapted to connect applicator cable 2334 to generator 2301 , including connections for cooling conduit 2324 , antenna switch signal 2481 , energy cable 2322 , cooling plate thermocouple wires 2330 and coolant thermocouple wires 2331 .
  • FIG. 2 is a perspective view of a medical treatment device 2300 including an applicator 2320 and disposable 2363 according to an embodiment of the invention.
  • applicator 2320 may be attached to disposable 2363 by latching mechanism 2365 .
  • applicator 2320 may include applicator cable 2334 .
  • disposable 2363 may include vacuum tubing 2319 , tissue chamber 2338 and tissue interface surface 2336 .
  • FIG. 3 is an end on view of a distal end of a medical treatment device 2300 including an applicator 2320 and disposable 2363 according to an embodiment of the invention.
  • disposable 2363 may include tissue bio-barrier 2337 .
  • applicator 2320 may include cooling plate 2340 , which may be, for example, positioned behind tissue bio-barrier 2337 .
  • tissue bio-barrier 2337 may form a portion of tissue interface surface 2336 .
  • latching mechanism 2365 may be used to facilitate the connection of disposable 2363 to applicator 2320 .
  • FIG. 4 is a perspective view of a medical treatment device 2300 including an exploded perspective view of an applicator 2320 and a view of disposable 2363 according to the present invention.
  • applicator 2320 may include a cooling plate 2340 , separation ribs 2393 , intermediate scattering elements 3393 , antenna cradle 2374 , waveguide assembly 2358 and antenna switch 2357 .
  • waveguide assembly 2358 may include antennas 2364 ( a - d ).
  • disposable 2363 may include vacuum tubing 2319 , latching elements 2359 and vacuum seal 2348 .
  • FIG. 5 is a view of a medical treatment device 2300 according to an embodiment of the present invention including a cutaway view of applicator 2320 and disposable 2363 .
  • applicator 2320 may include antenna array 2355 , antenna switch 2357 and applicator cable 2334 .
  • applicator cable 2334 may include cooling plate thermocouple wires 2330 , coolant thermocouple wires 2331 , coolant supply tubing 2312 , coolant return tubing 2313 , antenna switch signal 2481 , energy cable 2322 .
  • cooling plate thermocouple wires 2330 may include one or more thermocouple wires which may be attached to an or more thermocouples positioned opposite an output of antenna array 2355 .
  • coolant thermocouple wires 2331 may include one or more thermocouple wires attached to an or more cooling path thermocouples 2326 which may be positioned to measure coolant fluid, such as, for example, in coolant return tubing 2313 .
  • one or more cooling path thermocouples 2326 may be positioned to measure the temperature of cooling fluid 2361 after it passes through coolant chamber 2360 .
  • one or more cooling path thermocouples 2326 may be located in coolant return tubing 2313 .
  • cooling path thermocouples 2326 may function to provide feedback to generator 2301 indicative of the temperature of cooling fluid 2361 after cooling fluid 2361 passes through coolant chamber 2360 .
  • disposable 2363 may include latching element 2359 .
  • applicator cable 2334 may include interconnect cables 2372 to transmit signals to antenna array 2355 .
  • antenna array 2355 may include antenna cradle 2374 .
  • FIG. 6 is a perspective view of disposable 2363 according to an embodiment of the invention.
  • FIG. 7 is a view of the proximal side of disposable 2363 according to an embodiment of the invention.
  • FIG. 8 is a side view of one end of disposable 2363 according to an embodiment of the invention.
  • FIG. 9 is a side view of one end of disposable 2363 according to an embodiment of the invention.
  • FIG. 10 is a view of the distal side of disposable 2363 according to an embodiment of the invention.
  • FIG. 11 is a side view of disposable 2363 according to an embodiment of the invention.
  • FIG. 12 is a cutaway side view of disposable 2363 according to an embodiment of the invention.
  • FIG. 13 is a cutaway side view of disposable 2363 according to an embodiment of the invention.
  • FIG. 14 is a cutaway perspective view of disposable 2363 according to an embodiment of the invention.
  • FIG. 15 is a top perspective view of a proximal end of disposable 2363 according to an embodiment of the invention.
  • tissue interface surface 2336 may form a back wall of tissue chamber 2338 .
  • tissue interface surface 2336 may include tissue bio-barrier 2337 and vacuum passage 3333 .
  • vacuum passage 3333 may also be referred to as a lip or rim.
  • disposable 2363 may include alignment features 3352 and vacuum tubing 2319 .
  • compliant member 2375 may be included in compliant member 2375 .
  • chamber walls 2354 may include a compliant member 2375 .
  • compliant member 2375 may be formed from a compliant material, such as, for example, rubber, coated urethane foam (with a compliant plastic or rubber seal coating), silicone, polyurethane or heat sealed open cell foam. According to an embodiment of the invention compliant member 2375 may be positioned around the outer edge of tissue chamber 2338 to facilitate the acquisition of tissue. According to an embodiment of the invention compliant member 2375 may be positioned around the outer edge of chamber opening 2339 to facilitate the acquisition of tissue. According to an embodiment of the invention compliant member 2375 may facilitate the engagement of tissue which is not flat, such as, for example tissue in the axilla.
  • compliant member 2375 may facilitate the engagement of tissue which is not flat, such as, for example tissue in the outer regions of the axilla. According to an embodiment of the invention compliant member 2375 may provide improved sealing characteristics between the skin and tissue chamber 2338 , particularly where the skin is not flat. According to an embodiment of the invention compliant member 2375 may speed the acquisition of tissue in tissue chamber 2338 , particularly where the skin is not flat. According to an embodiment of the invention compliant member 2375 may have a height of between approximately 0.15 inches and approximately 0.40 inches above chamber opening 2339 when compliant member 2375 is not compressed. According to an embodiment of the invention compliant member 2375 may have a height of approximately 0.25 inches above chamber opening 2339 when compliant member 2375 is not compressed.
  • alignment features 3352 may be positioned at a distance which facilitate appropriate placement of applicator 2320 during treatment. According to an embodiment of the invention alignment features 3352 may be positioned approximately 30.7 millimeters apart. According to an embodiment of the invention alignment features 3352 may be further positioned and may be designed to assist a physician in positioning applicator 2320 prior to the application of energy. According to an embodiment of the invention alignment features 3352 on disposable 2363 assist the user in properly positioning the applicator prior to treatment and in moving the applicator to the next treatment region during a procedure. According to an embodiment of the invention alignment features 3352 on disposable 2363 , when used with marks or landmarks in a treatment region facilitate the creation of a continuous lesion. According to an embodiment of the invention alignment features 3352 may be used to align medical treatment device 2300 before suction is applied. According to an embodiment of the invention an outer edge of compliant member 2375 may assist a user in aligning medical treatment device 2300 .
  • compliant member 2375 which may also be referred to as a skirt or flexible skirt, may be manufactured from silicone. According to an embodiment of the invention compliant member 2375 may extend approximately 0.25′′ from rigid surface 3500 . According to an embodiment of the invention a counter sink or dovetail notch 2356 may be positioned in rigid disposable surface 3500 around the outer edge of chamber opening 2339 to assist in alignment of compliant member 2375 . According to an embodiment of the invention the compliant member 2375 may have a durometer density rating (softness) of approximately A60 which may help compliant member 2375 to maintain its shape better while being easier to mold.
  • colorant may be used in compliant member 2375 to contrast with skin viewed through compliant member 2375 , making it easier for user, such as a physician to distinguish between skin and a distal surface of compliant member 2375 .
  • colorant may be used in compliant member 2375 to make it easier for user, such as a physician to distinguish between skin and an outer edge of compliant member 2375 .
  • colorant may be used in compliant member 2375 to help a user distinguish an edge of compliant member 2375 from surrounding skin and assist in aligning of medical treatment device 2300 .
  • the angle of compliant member 2375 relative to rigid surface 3500 may be approximately 53 degrees when compliant member 2375 is not compressed.
  • disposable 2363 includes applicator chamber 2346 .
  • disposable 2363 may include an applicator chamber 2346 which may be formed, at least in part, by tissue bio-barrier 2337 .
  • disposable 2363 may include applicator bio-barrier 2332 (which may be, for example, a polyethylene film, available from Fisher Scientific), and vacuum passage 3333 .
  • a counter bore may positioned between applicator bio-barrier 2332 and applicator chamber 2346 .
  • vacuum passage 3333 connects vacuum channel 3350 to tissue chamber 2338 .
  • vacuum channel 3350 may also be referred to as a reservoir or vacuum reservoir.
  • vacuum connector 2328 is connected to vacuum passage 3333 through vacuum channel 3350 .
  • vacuum channel 3350 may connect vacuum passages 3333 connect vacuum connector 2328 in tissue chamber 2338 .
  • vacuum passages 3333 form a direct path to tissue interface surface 2336 .
  • vacuum passages 3333 and vacuum channel 3350 may be adapted to restrict the movement of fluids from tissue chamber 2338 to applicator bio-barrier 2332 .
  • vacuum connector 2328 may be positioned on the same side of disposable 2363 as applicator bio-barrier 2332 .
  • applicator bio-barrier 2332 may be designed to prevent fluids from tissue chamber 2338 from reaching applicator chamber 2346 , particularly when there is back pressure caused by, for example, a vacuum created in tissue chamber 2338 as tissue is pulled away from tissue interface surface 2336 .
  • vacuum pressure may be used to support tissue acquisition in tissue chamber 2338 .
  • vacuum pressure may be used to pull tissue into tissue chamber 2338 .
  • vacuum pressure may be used to maintain tissue in tissue chamber 2338 .
  • vacuum channel 2350 may surround tissue interface surface 2336 .
  • applicator bio-barrier 2332 may be positioned between vacuum passages 3333 and applicator chamber 2346 .
  • applicator bio-barrier 2332 may be a membrane which may be adapted to be permeable to air but substantially impermeable to biological fluids such as, for example, blood and sweat.
  • applicator bio-barrier 2332 may be a hydrophobic membrane filter.
  • applicator bio-barrier 2332 may be made of polyethylene film, nylon or other suitable materials.
  • applicator bio-barrier 2332 may include pores having sizes sufficient to pass enough air to substantially equalize the vacuum pressure in applicator chamber 2346 and in tissue chamber 2338 without passing biological fluids from tissue chamber 2338 to applicator chamber 2346 .
  • applicator bio-barrier 2332 may include pores having sizes of approximately 0.45 micrometers.
  • applicator bio-barrier 2332 when the vacuum is turned on, and before pressure is equalized, applicator bio-barrier 2332 may induce a minimal pressure drop between vacuum passages 3333 and the applicator chamber 2346 .
  • applicator chamber 2346 and tissue chamber 2338 may be separated, at least in part, by tissue bio-barrier 2337 .
  • tissue chamber 2338 may include tissue interface surface 2336 and chamber wall 2354 .
  • tissue chamber opening 2339 has dimensions which facilitate the acquisition of tissue.
  • tissue chamber 2339 may be sized to facilitate tissue acquisition while being large enough to prevent interference with energy radiated from waveguide antennas 2364 in antenna array 2355 when applicator 2320 is attached to disposable 2363 .
  • a vacuum circuit 3341 may include vacuum passages 3333 , vacuum channel 3350 and may encircle tissue chamber 3338 .
  • vacuum channel 3350 may be positioned around tissue chamber 2338 .
  • vacuum passage 3333 may be positioned around a proximal end of tissue chamber 2338 .
  • vacuum passage 3333 may be positioned around a proximal end of tissue chamber 2338 between tissue bio-barrier 2337 and a proximal end of chamber wall 2354 .
  • an opening to vacuum passage 3333 may be approximately 0.020 inches in height.
  • an opening to vacuum passage 3333 may be approximately 0.010 inches in height when disposable 2363 is attached to applicator 2320 and tissue bio-barrier 2337 is stretched into tissue chamber 2338 by a distal end of applicator 2320 .
  • vacuum passage 3333 may have an opening height which is too small for tissue to invade when a vacuum is applied.
  • disposable 2363 may be manufactured from a clear or substantially clear material to assist a user, such as a physician in viewing tissue engagement.
  • the disposable 2363 may have an outer angle to allow a user to see alignment features 3352 on compliant member 2375 to assist a user in aligning medical treatment device 2300 .
  • an angle around the outside of disposable 2363 provides a user with a direct view of alignment features 3352 .
  • tissue chamber 2338 may have dimensions of approximately 1.54 inches by approximately 0.7 inches.
  • the 4 corners of tissue chamber 2338 may have a radius of 0.1875 inches.
  • antenna array 2335 may include four antennas and may have dimensions of approximately 1.34 inches by approximately 0.628 inches.
  • the dimensions of the waveguide array 2335 and tissue chamber 2338 may be optimized to minimizing stray fields forming at the edges of waveguide array 2335 as well as optimizing the effective cooling area of tissue interface surface 2336 .
  • tissue chamber 2338 may be optimized to facilitate tissue acquisition without adversely impacting cooling or energy transmission.
  • FIG. 16 is a perspective view of antenna array 2355 according to an embodiment of the invention.
  • antenna array 2355 may include antenna cradle 2374 .
  • antenna cradle 2374 may include reservoir inlet 2384 and antenna chamber 2377 .
  • waveguide assembly 2358 may include one or more spacer 3391 (which may be, for example, copper shims) positioned between waveguide antennas 2364 .
  • spacer 3391 may be positioned between waveguide antenna 2364 a and waveguide antenna 2364 b.
  • spacer 3391 may be positioned between waveguide antenna 2364 b and waveguide antenna 2364 c.
  • spacer 3391 may be positioned between waveguide antenna 2364 c and waveguide antenna 2364 d.
  • microwave energy may be supplied to each waveguide antenna through feed connectors 2388 .
  • waveguide assembly 2358 may be held together by a waveguide assembly frame 2353 .
  • waveguide assembly frame 2353 may include feed brackets 2351 and assembly bolts 2349 .
  • antenna array 2355 may include antenna cradle 2374 and least one waveguide antenna 2364 .
  • antenna array 2355 may include one or more spacer 3391 .
  • antenna array 2355 may include four waveguide antennas 2364 a, 2364 b, 2364 c and 2364 d. According to an embodiment of the invention the heights of waveguide antennas 2364 in antenna array 2355 may be staggered to facilitate access to feed connectors 2388 . According to an embodiment of the invention one or more waveguide antenna 2364 in antenna array 2355 may include tuning element 2390 .
  • FIG. 17 is an end view of a portion of antenna array 2355 according to an embodiment of the invention.
  • FIG. 18 is a cutaway side view of a portion antenna array 2355 according to an embodiment of the invention.
  • FIG. 19 is a cutaway side view of a portion antenna array 2355 according to an embodiment of the invention.
  • antenna array 2355 includes coolant chambers 2360 (for example coolant chambers 2360 a, 2360 b, 2360 c and 2360 d ), intermediate scattering elements 3393 , separation ribs 2393 and scattering elements 2378 (for example scattering elements 2378 a, 2378 b, 2378 c and 2378 d ).
  • scattering elements 2378 may also be referred to as central scattering elements.
  • coolant chambers 2360 a - 2360 d may be located beneath waveguide antenna 2364 a - 2364 d.
  • coolant chambers 2360 may include separation ribs 2393 on either side of antenna array 2355 and intermediate scattering elements 3393 between antennas 2364 .
  • an intermediate scattering element 3393 may be positioned between waveguide antenna 2364 a and waveguide antenna 2364 b.
  • an intermediate scattering element 3393 may be positioned between waveguide antenna 2364 b and waveguide antenna 2364 c.
  • an intermediate scattering element 3393 may be positioned between waveguide antenna 2364 c and waveguide antenna 2364 d.
  • cooling fluid flowing through coolant chambers 2360 may have a flow rate of between approximately 200 milliliters per minute and approximately 450 milliliters per minute and preferably approximately 430 milliliters per minute.
  • coolant chambers 2360 may be designed to ensure that the flow rate through each coolant chamber 2360 is substantially the same.
  • coolant the flow rate of cooling fluid through coolant chamber 2360 a is the same as the flow rate of cooling fluid through coolant chamber 2360 b.
  • coolant the flow rate of cooling fluid through coolant chamber 2360 a is the same as the flow rate of cooling fluid through coolant chambers 2360 b, 2360 c and 2360 d.
  • cooling fluid flowing through coolant chamber 2360 may have a temperature of between approximately 8 degrees centigrade and approximately 22 degrees centigrade and preferably approximately 15 degrees centigrade.
  • coolant chambers 2360 may be positioned between an aperture of waveguide antenna 2364 cooling plate 2340 .
  • scattering elements 2378 may extend into at least a portion of coolant chambers 2360 .
  • scattering elements 2378 may extend through coolant chambers 2360 .
  • scattering elements 2378 and intermediate scattering elements 3393 may extend through coolant chambers 2360 to contact a proximal surface of cooling plate 2340 .
  • elements of coolant chamber 2360 may be smoothed or rounded to promote laminar fluid flow through coolant chambers 2360 .
  • elements of coolant chambers 2360 may be smoothed to reduce the generation of air bubbles in coolant chamber 2360 .
  • scattering elements 2378 which extend into coolant chambers 2360 may be rounded to promote laminar flow and prevent the buildup of bubbles in coolant chamber 2360 .
  • scattering elements 2378 may be formed in the shape of ovals or racetracks.
  • intermediate scattering elements 3393 may be positioned between separate individual coolant chambers 2360 . According to an embodiment of the invention intermediate scattering elements 3393 may be positioned such that they facilitate equalized cooling across cooling plate 2340 . According to an embodiment of the invention intermediate scattering elements 3393 may be sized such that they have a width which is equal to or less than the separation distance between apertures of waveguide antennas 2364 . According to an embodiment of the invention intermediate scattering elements 3393 may be sized and positioned such that they are not positioned an aperture of waveguide antenna 2364 .
  • intermediate scattering elements 3393 may be sized and positioned such that they modify a microwave field as it travels through coolant chamber 2360 . According to an embodiment of the invention intermediate scattering elements 3393 may be sized and positioned such that they modify a microwave field radiated from waveguide antenna 2364 . According to an embodiment of the invention intermediate scattering elements 3393 may be sized and positioned such that they spread out a microwave field as it travels through coolant chamber 2360 . According to an embodiment of the invention intermediate scattering elements 3393 may cause disruption or perturbation of microwave energy radiated from waveguide antenna 2364 . According to an embodiment of the invention intermediate scattering elements 3393 may be made of materials which will not rust or degrade in cooling fluid.
  • intermediate scattering elements 3393 may be made of materials which improve the SAR pattern in tissue.
  • intermediate scattering elements 3393 may be made of materials, such as dielectric materials, which are used to form scattering elements 2378 .
  • FIGS. 17 through 19 may also include waveguide assembly 2358 , feed connectors 2388 , antenna chamber 2377 , spacers 3391 , cradle channels 2389 and antenna cradle 2374 .
  • intermediate scattering elements 3393 may be positioned between waveguide antennas 2364 .
  • the size and shape of the intermediate scattering elements 3393 may be designed to optimize the size and shape of lesions developed in the skin between waveguide antennas 2364 .
  • intermediate scattering elements 3393 may make lesions created in tissue between waveguide antennas 2364 larger and more spread out.
  • intermediate scattering elements 3393 may make lesions created in tissue between waveguide antennas 2364 narrower.
  • intermediate scattering elements 3393 may have an optimal length which is shorter than the length of scattering elements 2378 .
  • scattering elements 2378 may be approximately 7 millimeters in length.
  • intermediate scattering elements 3393 may have an optimal length which is approximately 6.8 millimeters. According to an embodiment of the invention intermediate scattering elements 3393 may be manufactured from, for example, alumina. According to an embodiment of the invention intermediate scattering elements 3393 may be manufactured from, for example, a material which is approximately 96% alumina. According to an embodiment of the invention intermediate scattering elements 3393 may be manufactured from, for example, silicone. According to an embodiment of the invention the intermediate scattering elements 3393 may be manufactured from a material having the same dielectric constant as scattering elements 2378 . According to an embodiment of the invention the intermediate scattering elements 3393 may be manufactured from a material having approximately the same dielectric constant as scattering elements 2378 .
  • intermediate scattering elements 3393 may be manufactured from a material having a dielectric constant of approximately 10. According to an embodiment of the invention intermediate scattering elements 3393 may be manufactured from a material having a dielectric constant of approximately 3. According to an embodiment of the invention increasing the dielectric constant of intermediate scattering element 3393 may reduce the size of a lesion created in skin between waveguide antennas 2364 . According to an embodiment of the invention intermediate scattering elements 3393 may be inserted into tongue and groove slots between wave antennas 2364 . According to an embodiment of the invention thermocouples may be positioned beneath one or more of intermediate scattering elements 3393 . According to an embodiment of the invention thermocouples may be positioned each of intermediate scattering elements 3393 .
  • FIGS. 20, 21 and 22 are simplified cutaway views of a medical treatment device 2300 with tissue engaged according to an embodiment of the invention.
  • skin 1307 is engaged in treatment device 2300 .
  • dermis 1305 and hypodermis 1303 are engaged in medical treatment device 2300 .
  • skin surface 1306 is engaged in medical treatment device 2300 such that skin surface 1306 is in thermal contact with at least a portion of cooling plate 2340 .
  • skin surface 1306 is engaged in medical treatment device 2300 such that skin surface 1306 is in contact with at least a portion of tissue interface 2336 .
  • a vacuum pressure may be used to elevate dermis 1305 and hypodermis 1303 , separating dermis 1305 and hypodermis 1303 from muscle 1301 .
  • vacuum pressure may be used to elevate dermis 1305 and hypodermis 1303 , separating dermis 1305 and hypodermis 1303 from muscle 1301 to, for example, protect muscle 1301 by limiting or eliminating the electromagnetic energy which reaches muscle 1301 .
  • waveguide assembly 2358 may include one or more waveguide antennas 2364 .
  • electromagnetic energy such as, for example, microwave energy may be radiated into dermis 1305 by medical treatment device 2300 .
  • medical treatment device 2300 may include coolant chamber 2360 and cooling plate 2340 .
  • a peak which may be, for example, a peak SAR, peak power loss density or peak temperature, is generated in first tissue region 1309 .
  • first tissue region 1309 may represent a lesion created by energy, such as, for example, microwave energy radiated from medical treatment device 2300 .
  • first tissue region 1309 may represent a lesion created by microwave energy radiated from one or more of waveguide antennas 2364 .
  • first tissue region 1309 may be initiated in skin 1307 between first waveguide antenna 2364 and a second waveguide antenna 2364 .
  • first tissue region 1309 may be initiated in skin 1307 between first waveguide antenna 2364 a and a second waveguide antenna 2364 b. According to an embodiment of the invention first tissue region 1309 may be initiated in skin 1307 underlying intermediate scattering element 3393 . According to an embodiment of the invention a reduced magnitude which may be, for example, a reduced SAR, reduced power loss density or reduced temperature, is generated in second tissue region 1311 with further reduced magnitudes in third tissue region 1313 and fourth tissue region 1315 . As illustrated in FIGS. 20 through 22 , dermis 1305 is separated from hypodermis 1303 by interface 1308 . As illustrated in FIGS.
  • interface 1308 may be idealized as a substantially straight line for the purposes of simplified illustration however in actual tissue, interface 1308 may be a non-linear, non-continuous, rough interface which may also include many tissue structures and groups of tissue structures which cross and interrupt tissue interface 1308 .
  • electromagnetic radiation may be radiated at a frequency of, for example, between 5 and 6.5 GHz.
  • electromagnetic radiation may be radiated at a frequency of, for example, approximately 5.8 GHz.
  • scattering element 2378 may be located in coolant chamber 2360 and intermediate scattering elements 3393 may be located between coolant chambers 2360 .
  • scattering element 2378 and intermediate scattering elements 3393 may be used to, for example, spread and flatten first tissue region 1309 .
  • scattering element 2378 and intermediate scattering elements 3393 may be used to, for example, spread and flatten a region, such as first tissue region 1309 , of peak SAR in tissue.
  • scattering element 2378 and intermediate scattering elements 3393 may be used to, for example, spread and flatten a region, such as first tissue region 1309 , of peak power loss density in tissue.
  • scattering element 2378 and intermediate scattering elements 3393 may be used to, for example, spread and flatten a region, such as first tissue region 1309 , of peak temperature in tissue.
  • scattering element 2378 and scattering elements 3393 may be used to, for example, spread and flatten lesions formed in first tissue region 1309 .
  • the creation of lesions such as for example, a lesion in tissue region 1309 may be used to treat the skin of patients.
  • the creation of lesions, such as for example, a lesion in tissue region 1309 may be used to damage or destroy structures, such as, for example, sweat glands in the skin of a patient.
  • FIG. 23 is a graphical illustration of a pattern of lesions in tissue according to an embodiment of the invention.
  • lesions may be created in a predetermined order, such as, for example A-B-C-D where: A represents a lesion initiated directly under waveguide antenna 2364 a; B represents a lesion initiated directly under waveguide antenna 2364 b; C represents a lesion initiated directly under waveguide antenna 2364 c; D represents a lesion initiated directly under waveguide antenna 2364 d.
  • lesions may be created in a predetermined order such as, for example, A-AB-B-BC-C-CD-D where: A represents a lesion initiated directly under waveguide antenna 2364 a; AB represents a lesion initiated under the intersection between waveguide antenna 2364 a and waveguide antenna 2364 b; B represents a lesion initiated directly under waveguide antenna 2364 b; BC represents a lesion initiated under the intersection between waveguide antenna 2364 b and waveguide antenna 2364 c; C represents a lesion initiated directly under waveguide antenna 2364 c; CD represents a lesion initiated under the intersection between waveguide antenna 2364 c and waveguide antenna 2364 d; and D represents a lesion initiated directly under waveguide antenna 2364 d.
  • A represents a lesion initiated directly under waveguide antenna 2364 a
  • AB represents a lesion initiated under the intersection between waveguide antenna 2364 a and waveguide antenna 2364 b
  • B represents a lesion initiated directly under waveguide antenna 2364 b
  • BC represents a
  • a lesion AB may be created between waveguide antenna 2364 a and waveguide antenna 2364 b, by driving waveguide antenna 2364 a and waveguide antenna 2364 b simultaneously in phase and with a balanced output from each antenna.
  • a lesion BC may be created between waveguide antenna 2364 b and waveguide antenna 2364 c, by driving waveguide antenna 2364 b and waveguide antenna 2364 c simultaneously in phase and with a balanced output from each waveguide antenna.
  • a lesion CD may be created between waveguide antenna 2364 c and waveguide antenna 2364 d, by driving waveguide antenna 2364 c and waveguide antenna 2364 d simultaneously in phase and with a balanced output from each waveguide antenna.
  • FIG. 24 is a treatment template 2483 according to an embodiment of the invention.
  • treatment template 2483 may include axilla outline 2497 , anesthesia injection sites 2485 , landmark alignment marks 2497 , device alignment points 2498 and device alignment lines 2499 .
  • axilla outline 2497 may be matched to the hair bearing area of a patient to select an appropriate treatment template 2483 .
  • anesthesia injection sites 2485 may be used to identify appropriate points in the axilla for the injection of anesthesia.
  • landmark alignment marks may be used to align treatment template 2483 to landmarks, such as, for example, tattoos or moles on the axilla.
  • device alignment points 2498 may be used in conjunction with alignment features 3352 to properly align medical treatment device 2300 .
  • device alignment lines 2499 may be used in conjunction with an outer edge of compliant member 2375 to properly align medical treatment device 2300 .
  • treatment template 2384 provides guidance and placement information for medical treatment device 2300 in matrix format.
  • a medical device disposable may include: a tissue chamber may have a tissue opening at a distal end and a rigid surface surrounding the tissue opening; an applicator chamber; a flexible bio-barrier at a proximal end of the tissue chamber the flexible bio-barrier separating the tissue chamber and the applicator chamber, a portion of the flexible bio-barrier forming a tissue contacting surface; a compliant member surrounding the tissue opening, the compliant member may have a proximal opening adjacent the tissue opening and a distal opening, wherein the distal opening may be larger than the proximal opening.
  • the medical device disposable compliant member may be positioned at an angle of approximately fifty-three degrees with respect to the rigid surface.
  • the compliant member may include a wall connecting the proximal opening and the distal opening and the wall may be angled approximately fifty-three degrees with respect to the rigid surface.
  • the compliant member may further include an outer rim positioned around the distal opening.
  • the outer rim may extend a distance of approximately 0.033 inches from the distal opening;
  • the compliant member may have a height of approximately 0.25 inches;
  • the tissue opening may have a long axis and a short axis, the tissue opening long axis may be approximately 1.875 inches and the tissue opening short axis may be approximately 1.055 inches;
  • the distal opening in the compliant member may have a long axis and a short axis, the distal opening long axis may be approximately 2.429 inches and the distal opening short axis may be approximately 1.609 inches;
  • the tissue contact surface may have a long axis and a short axis, the long axis may be approximately 1.54 inches and the short axis may be approximately 0.700 inches.
  • the wall may be substantially straight.
  • the compliant member may include one or more alignment marks, at least one of the alignment marks may be positioned on a long side of the compliant member.
  • the alignment marks may be positioned on a wall of the skirt and may extend from approximately the rim toward the tissue opening.
  • the alignment marks may move with respect to an applicator positioned in the applicator chamber when the medical device disposable is pressed against tissue with sufficient pressure to compress the compliant member.
  • the wall may have a thickness of approximately 0.050 inches.
  • the tissue chamber may include a chamber wall extending from the tissue opening to approximately the tissue contact surface, the wall may also include a substantially smooth, radiused surface.
  • the radiused surface may have a radius of approximately three-sixteenths of an inch.
  • the compliant member may have durometer density rating of approximately A60.
  • a medical device disposable may include: a tissue chamber including a tissue contact surface at a proximal end of the tissue chamber and a tissue opening at a distal end of the tissue chamber; an applicator chamber; a flexible bio-barrier at a proximal end of the tissue chamber the flexible bio-barrier separating the tissue chamber and the applicator chamber, the flexible bio-barrier forming at least a portion of the tissue contact surface; a vacuum port; a vacuum circuit connecting the tissue chamber, the applicator chamber and the vacuum port, the vacuum circuit including a vacuum passage.
  • the vacuum circuit may include: a vacuum passage positioned around the tissue contact surface; a vacuum channel positioned around the vacuum passage, the vacuum channel positioned between the vacuum passage and the vacuum port; an applicator bio-barrier positioned between the vacuum port and the applicator chamber, the applicator bio-barrier being substantially permeable to air and substantially impermeable to fluids.
  • the vacuum passage may completely surround the tissue interface surface.
  • the vacuum passage may substantially surrounds the tissue interface surface.
  • the vacuum passage may be positioned in a wall of the tissue chamber adjacent the tissue contact surface.
  • vacuum port may be connected to a vacuum tube.
  • the vacuum tube may include a generator bio-barrier.
  • the generator bio-barrier may be substantially permeable to air and being substantially impermeable to fluids.
  • the vacuum channel may include a well region adapted to collect fluids from the tissue chamber.
  • a compliant member may surround the tissue opening, the compliant member may have a proximal opening adjacent the tissue opening and a distal opening, wherein the distal opening may be larger than the proximal opening.
  • the vacuum passage may be an opening between a wall of the tissue chamber and the tissue bio-barrier.
  • the vacuum passage may be approximately 0.020′′ inches wide.
  • the vacuum passage may be greater than approximately 0.010′′ inches when the medical device disposable may be attached to an applicator.
  • the tissue surface may have an area greater than an outer area of an antenna array in an applicator affixed to the medical device disposable.
  • the tissue surface may have an area greater than an aperture area of an antenna array in an applicator affixed to the medical device disposable.
  • a method of creating a lesion in skin including the steps of: positioning an apparatus including a plurality of antennas adjacent a skin surface; supplying energy to a first antenna at a first power level for a first time period; supplying energy to a second antenna at a second power level for a second time period; supplying energy simultaneously to both the first antenna and the second antenna for a third time period, wherein, during the third time period the energy may be supplied to the first antenna at a third power level and the energy may be supplied to the second antenna at a fourth power level.
  • the energy supplied to the first antenna may be in phase with the energy supplied to the second antenna.
  • the energy supplied to the first antenna may be phase shifted from the energy supplied to the second antenna.
  • the energy supplied to the first antenna may be phase shifted approximately one hundred eighty degrees from the energy supplied to the second antenna.
  • the energy supplied to the first antenna may be phase shifted between one and one hundred eighty degrees from the energy supplied to the second antenna.
  • the energy output from the first antenna may be substantially in phase with energy output from the second antenna.
  • the energy supplied to the first antenna may be phase shifted from the energy supplied to the second antenna, the phase shift being sufficient to cause energy output from the first antenna to be in phase with energy output from the second antenna.
  • the energy supplied to the first and second antennas may be microwave energy having a frequency of approximately 5.8 GHz.
  • the first and second antennas may be microwave antennas.
  • the first and second antennas may be waveguide antennas.
  • the first and the second power levels may be substantially equal.
  • the first power level may be greater than the second power level.
  • the power emitted by the first antenna may be substantially equal to power emitted by the second antenna.
  • a medical device applicator may include: an antenna array including at least two antenna apertures; at least one intermediate scattering element positioned outside the apertures wherein the at least one intermediate scattering element may be further positioned between the apertures.
  • each of the apertures may be substantially rectangular in shape, the apertures including a long axis and a short axis.
  • each of the intermediate scattering elements may include a long axis and a short axis wherein the long axis of the at least one intermediate scattering element may be substantially parallel to the long axis of the aperture.
  • the medical device applicator may include a cooling plate and the intermediate scattering element may be positioned between the antenna apertures and the cooling plate.
  • the medical device applicator may further include one or more coolant chambers positioned between the cooling plate and the antenna aperture.
  • the medical device applicator may include at least two central scattering elements positioned under the aperture wherein the at least one intermediate scattering element may be positioned between the central scattering elements.
  • the central scattering elements may be positioned substantially in a center of one of the antenna apertures.
  • the long axis of the intermediate scattering element may be shorter than the longest dimension of the central scattering element.
  • the intermediate scattering element may be manufactured from a material which may have the same dielectric constant as the central scattering element.
  • the intermediate scattering element may be made from alumina.
  • the intermediate scattering element may be made from a material which may be more than 90 percent alumina.
  • the intermediate scattering element may be made from a material which may be approximately 96 percent alumina.
  • the intermediate scattering element may be made from, for example silicone.
  • one or more temperature measurement devices may be positioned on the cooling plate under the intermediate scattering element.
  • the one or more temperature measurement device may be one or more thermocouples.
  • a medical device applicator may include at least a first and a second waveguide antenna and at least a first electrically conductive shim positioned between the waveguide antennas.
  • each of the waveguide antennas may include: a dielectric core having four sides; metal plating on three sides of the dielectric core, the fourth side of the dielectric core forming an antenna aperture.
  • the electrically conductive shim may be copper.
  • the electrically conductive shim may be approximately 0.025 inches thick.
  • the electrically conductive shim may be positioned between the first and second waveguide antennas such that an edge of the electrically conductive shim may be adjacent the antenna apertures.
  • an intermediate scattering element may be positioned under the conductive shim.
  • central scattering elements may be positioned under the antenna apertures.
  • the medical device applicator may include a cooling plate.
  • the intermediate scattering element and the central scattering element may be positioned between the antenna apertures and the cooling plate.
  • the medical device applicator may include a coolant chamber positioned between the antenna apertures and the cooling plate.
  • the medical device applicator may include temperature sensors positioned on the cooling plate.

Abstract

The present invention is directed to systems, apparatus, methods and procedures for the noninvasive treatment of tissue, including treatment using microwave energy. In one embodiment of the invention a medical device and associated apparatus and procedures are used to treat dermatological conditions using, for example, microwave energy.

Description

    CROSS REFERENCE TO RELATED APPLICATIONS
  • This application is a continuation of U.S. application Ser. No. 12/988,165, filed Oct. 15, 2010, now U.S. Pat. No. 9,241,763, which application is the national stage of International Application No. PCT/US2009/002403, filed Apr. 17, 2009.
  • Said International Application No. PCT/US2009/002403 claims the benefit of U.S. Provisional Application No. 61/208,315, filed Feb. 23, 2009, and also claims the benefit of PCT Application No. PCT/US2008/013650, filed Dec. 12, 2008. Further, said International Application No. PCT/US2009/002403, also claims the benefit of U.S. Provisional Patent Application No. 61/196,948, filed Oct. 22, 2008.
  • Said International Application No. PCT/US2009/002403 also is a continuation-in-part of co-pending U.S. application Ser. No. 12/107,025, filed Apr. 21, 2008, which claims the benefit of each of U.S. Provisional Application No. 60/912,899, filed Apr. 19, 2007, and U.S. Provisional Application No. 61/013,274, filed Dec. 12, 2007, and U.S. Provisional Application No. 61/045,937, filed Apr. 17, 2008. All of the above priority applications are expressly incorporated by reference in their entirety.
  • Co-pending U.S. application Ser. No. 12/107,025 also claims priority to each of PCT Application No. PCT/US2008/060935, filed Apr. 18, 2008, and PCT Application No. PCT/US2008/060929, filed Apr. 18, 2008, and PCT Application No. PCT/US2008/060940, filed Apr.18, 2008, and PCT Application No. PCT/US2008/060922, filed Apr. 18, 2008. All of the above priority applications are expressly incorporated by reference in their entirety.
  • FIELD OF THE INVENTION
  • The present application relates to methods, apparatuses and systems for non-invasive delivery of energy, including microwave therapy. In particular, the present application relates to methods, apparatuses and systems for non-invasively delivering energy, such as, for example, microwave energy, to the epidermal, dermal and sub-dermal tissue of a patient to achieve various therapeutic and/or aesthetic results.
  • DESCRIPTION OF THE RELATED ART
  • It is known that energy-based therapies can be applied to tissue throughout the body to achieve numerous therapeutic and/or aesthetic results. There remains a continual need to improve on the effectiveness of these energy-based therapies and provide enhanced therapeutic results with minimal adverse side effects or discomfort.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • The invention will be understood from the following detailed description of preferred embodiments, taken in conjunction with the accompanying drawings, wherein:
  • FIG. 1 is an illustration of a system including a generator, applicator and disposable according to an embodiment of the invention.
  • FIG. 2 is a perspective view of a medical treatment device, including an applicator and disposable, according to an embodiment of the invention.
  • FIG. 3 is an end on view of the distal end of a medical treatment device, including an applicator and the disposable according to an embodiment of the invention.
  • FIG. 4 is an exploded perspective view of a medical treatment device according to an embodiment of the invention.
  • FIG. 5 is a view of a medical treatment device according to an embodiment of the invention including a cutaway view of applicator according to an embodiment of the invention.
  • FIG. 6 is a perspective view of a disposable according to an embodiment of the invention.
  • FIG. 7 is a view of a proximal side of a disposable according to an embodiment of the invention.
  • FIG. 8 is a side view of one end of a disposable according to an embodiment of the invention.
  • FIG. 9 is a side view of one end of a disposable according to an embodiment of the invention.
  • FIG. 10 is a view of a distal side of a disposable according to an embodiment of the invention.
  • FIG. 11 is a side view of a disposable according to an embodiment of the invention.
  • FIG. 12 is a cutaway side view of a disposable according to an embodiment of the invention.
  • FIG. 13 is a cutaway side view of a disposable according to an embodiment of the invention.
  • FIG. 14 is a cutaway perspective view of a disposable according to an embodiment of the invention.
  • FIG. 15 is a top perspective view of a proximal end of a disposable according to an embodiment of the invention.
  • FIG. 16 is a perspective view of an antenna array according to an embodiment of the invention.
  • FIG. 17 is an end view of a portion of an antenna array according to an embodiment of the invention.
  • FIG. 18 is a cutaway side view of a portion antenna array according to an embodiment of the invention.
  • FIG. 19 is a cutaway side view of a portion antenna array according to an embodiment of the invention.
  • FIG. 20 is a simplified cutaway view of a medical treatment device with tissue engaged according to an embodiment of the invention.
  • FIG. 21 is a simplified cutaway view of a medical treatment device with tissue engaged according to an embodiment of the invention.
  • FIG. 22 is a simplified cutaway view of a medical treatment device with tissue engaged according to an embodiment of the invention.
  • FIG. 23 is a graphical illustration of a pattern of lesions in tissue according to an embodiment of the invention.
  • FIG. 24 illustrates a treatment template according to an embodiment of the invention.
  • DESCRIPTION OF THE PREFERRED EMBODIMENT
  • Although the disclosure hereof is detailed and exact to enable those skilled in the art to practice the invention the physical embodiments herein disclosed merely exemplify the invention which may be embodied in other specific structures. While the preferred embodiment has been described, the details may be changed without departing from the invention which is defined by the claims.
  • FIG. 1 is an illustration of a system 2309 including a generator 2301, applicator 2320 (which may also be referred to as re-usable) and disposable 2363 according to an embodiment of the invention. According to an embodiment of the invention applicator 2320 and disposable 2363 may comprise a medical treatment device 2300. According to an embodiment of the invention generator 2301 may operate in the ISM band of 5.775 to 5.825 GHz. According to an embodiment of the invention generator 2301 may have a Frequency centered at approximately 5.8 GHz. According to an embodiment of the invention generator 2301 includes circuitry for setting and controlling output power; measuring forward and reverse power and setting alarms. According to an embodiment of the invention generator 2301 may have a power output of between approximately 40 Watts and approximately 100 Watts. According to an embodiment of the invention generator 2301 may have a power output of between approximately 40 Watts and approximately 100 Watts where said output is measured into a 50 ohm load. According to an embodiment of the invention generator 2301 may have a power output of approximately 55 Watts measured into a 50 ohm load. According to an embodiment of the invention disposable 2363 and applicator 2320 may be formed into two separable units. According to an embodiment of the invention disposable 2363 and applicator 2320 may be formed into a single unit. According to an embodiment of the invention when combined disposable 2363 and applicator 2320 may form a medical treatment device 2300. According to an embodiment of the invention generator 2301 may be a microwave generator. According to an embodiment of the invention in system 2309 applicator 2320 may be connected to generator 2301 by applicator cable 2334. According to an embodiment of the invention in system 2309 applicator cable 2334 may include coolant conduit 2324, energy cable 2322, coolant thermocouple wires 2331, cooling plate thermocouple wires 2330 and antenna switch signal 2481. According to an embodiment of the invention in system 2309 coolant conduit 2324 may be connected to a coolant source 2310 (which may be, for example, a Nanotherm industrial recirculation chiller with 8 pounds per square inch pump output pressure available from ThermoTek, Inc.). According to an embodiment of the invention in system 2309 energy cable 2322 may be connected to generator 2301 by microwave output connector 2443. According to an embodiment of the invention in system 2309 antenna switch signal 2481 may be connected to generator 2301 by antenna switch connector 2480. According to an embodiment of the invention in system 2309 disposable 2363 may be connected to generator 2301 by vacuum tubing 2319 which may include generator bio-barrier 2317, which may be, for example, a hydrophobic filter. According to an embodiment of the invention in system 2309 vacuum tubing 2319 may be connected to generator 2301 by vacuum port connector 2484. According to an embodiment of the invention in system 2309 front panel 2305 of generator 2301 may include power control knob 2454, vacuum control knob 2456, antenna select switch 2462 (which may include both display elements and selection switches), vacuum meter 2486, antenna temperature display 2458, coolant temperature display 2460, pre-cool timer 2468 (which may include both display elements and time set elements), energy timer 2470 (which may include both display elements and time set elements), post-cool timer 2472 (which may include both display elements and time set elements), start button 2464, stop button 2466, ready indicator 2476 and fault indicator 2474. According to an embodiment of the invention an error signal is sent to generator 2301 if a measured signal is outside of the specification for the requested power set by the power control knob 2454 on front panel 2305. According to an embodiment of the invention vacuum tube 2319 may include a flexible vacuum hose 2329 and a generator bio-barrier 2317. According to an embodiment of the invention flexible vacuum hose 2329 is adapted to collect fluids, such as, for example sweat or blood, which may escape disposable 2363 so that such fluids do not reach generator 2301. According to an embodiment of the invention generator bio-barrier 2317 may include a hydrophobic filter to keep fluids out of vacuum port connector 2484 of generator 2301. According to an embodiment of the invention generator bio-barrier 2317 may include a hydrophobic filter, such as, for example, a Millex FH Filter made of 0.45 micrometer hydrophobic PTFE which is available from Milipore. According to an embodiment of the invention generator bio-barrier 2317 may be positioned in vacuum tube 2319 between flexible vacuum hose 2329 and vacuum port connector 2484. According to an embodiment of the invention applicator cable 2334 may connect generator 2301 to applicator 2320. According to an embodiment of the invention cooling plate thermocouple wires 2330 and coolant thermocouple wires 2331 may be connected to generator 2301 by temperature connector 2482. According to an embodiment of the invention coolant conduit 2324 may convey cooling fluid from a coolant source 2310 to applicator 2320. According to an embodiment of the invention applicator cable 2334 may convey microwave switch selection data to applicator 2320 and temperature data from thermocouples in applicator 2320 to generator 2301. According to an embodiment of the invention applicator cable 2334 may comprise one or more separate cables and connectors. According to an embodiment of the invention a generator connector may be designed and adapted to connect applicator cable 2334 to generator 2301, including connections for cooling conduit 2324, antenna switch signal 2481, energy cable 2322, cooling plate thermocouple wires 2330 and coolant thermocouple wires 2331.
  • FIG. 2 is a perspective view of a medical treatment device 2300 including an applicator 2320 and disposable 2363 according to an embodiment of the invention. According to an embodiment of the invention applicator 2320 may be attached to disposable 2363 by latching mechanism 2365. According to an embodiment of the invention applicator 2320 may include applicator cable 2334. According to an embodiment of the invention disposable 2363 may include vacuum tubing 2319, tissue chamber 2338 and tissue interface surface 2336.
  • FIG. 3 is an end on view of a distal end of a medical treatment device 2300 including an applicator 2320 and disposable 2363 according to an embodiment of the invention. According to an embodiment of the invention disposable 2363 may include tissue bio-barrier 2337. According to an embodiment of the invention applicator 2320 may include cooling plate 2340, which may be, for example, positioned behind tissue bio-barrier 2337. According to an embodiment of the invention tissue bio-barrier 2337 may form a portion of tissue interface surface 2336. According to an embodiment of the invention latching mechanism 2365 may be used to facilitate the connection of disposable 2363 to applicator 2320.
  • FIG. 4 is a perspective view of a medical treatment device 2300 including an exploded perspective view of an applicator 2320 and a view of disposable 2363 according to the present invention. According to an embodiment of the invention applicator 2320 may include a cooling plate 2340, separation ribs 2393, intermediate scattering elements 3393, antenna cradle 2374, waveguide assembly 2358 and antenna switch 2357. According to an embodiment of the invention waveguide assembly 2358 may include antennas 2364(a-d). According to an embodiment of the invention disposable 2363 may include vacuum tubing 2319, latching elements 2359 and vacuum seal 2348.
  • FIG. 5 is a view of a medical treatment device 2300 according to an embodiment of the present invention including a cutaway view of applicator 2320 and disposable 2363. According to an embodiment of the invention applicator 2320 may include antenna array 2355, antenna switch 2357 and applicator cable 2334. According to an embodiment of the invention applicator cable 2334 may include cooling plate thermocouple wires 2330, coolant thermocouple wires 2331, coolant supply tubing 2312, coolant return tubing 2313, antenna switch signal 2481, energy cable 2322. According to an embodiment of the invention cooling plate thermocouple wires 2330 may include one or more thermocouple wires which may be attached to an or more thermocouples positioned opposite an output of antenna array 2355. According to an embodiment of the invention coolant thermocouple wires 2331 may include one or more thermocouple wires attached to an or more cooling path thermocouples 2326 which may be positioned to measure coolant fluid, such as, for example, in coolant return tubing 2313. According to an embodiment of the invention one or more cooling path thermocouples 2326 may be positioned to measure the temperature of cooling fluid 2361 after it passes through coolant chamber 2360. According to an embodiment of the invention one or more cooling path thermocouples 2326 may be located in coolant return tubing 2313. According to an embodiment of the invention cooling path thermocouples 2326 may function to provide feedback to generator 2301 indicative of the temperature of cooling fluid 2361 after cooling fluid 2361 passes through coolant chamber 2360. According to an embodiment of the invention disposable 2363 may include latching element 2359. According to an embodiment of the invention applicator cable 2334 may include interconnect cables 2372 to transmit signals to antenna array 2355. According to an embodiment of the invention antenna array 2355 may include antenna cradle 2374.
  • FIG. 6 is a perspective view of disposable 2363 according to an embodiment of the invention. FIG. 7 is a view of the proximal side of disposable 2363 according to an embodiment of the invention. FIG. 8 is a side view of one end of disposable 2363 according to an embodiment of the invention. FIG. 9 is a side view of one end of disposable 2363 according to an embodiment of the invention. FIG. 10 is a view of the distal side of disposable 2363 according to an embodiment of the invention. FIG. 11 is a side view of disposable 2363 according to an embodiment of the invention. FIG. 12 is a cutaway side view of disposable 2363 according to an embodiment of the invention. FIG. 13 is a cutaway side view of disposable 2363 according to an embodiment of the invention. FIG. 14 is a cutaway perspective view of disposable 2363 according to an embodiment of the invention. FIG. 15 is a top perspective view of a proximal end of disposable 2363 according to an embodiment of the invention.
  • According to an embodiment of the invention disposable 2363 may include tissue interface surface 2336, tissue chamber 2338 and alignment features 3352. According to an embodiment of the invention tissue interface surface 2336 may form a back wall of tissue chamber 2338. According to an embodiment of the invention tissue interface surface 2336 may include tissue bio-barrier 2337 and vacuum passage 3333. According to an embodiment of the invention vacuum passage 3333 may also be referred to as a lip or rim. According to an embodiment of the invention disposable 2363 may include alignment features 3352 and vacuum tubing 2319. According to an embodiment of the invention disposable 2363 may include compliant member 2375. According to an embodiment of the invention chamber walls 2354 may include a compliant member 2375. According to an embodiment of the invention compliant member 2375 may be formed from a compliant material, such as, for example, rubber, coated urethane foam (with a compliant plastic or rubber seal coating), silicone, polyurethane or heat sealed open cell foam. According to an embodiment of the invention compliant member 2375 may be positioned around the outer edge of tissue chamber 2338 to facilitate the acquisition of tissue. According to an embodiment of the invention compliant member 2375 may be positioned around the outer edge of chamber opening 2339 to facilitate the acquisition of tissue. According to an embodiment of the invention compliant member 2375 may facilitate the engagement of tissue which is not flat, such as, for example tissue in the axilla. According to an embodiment of the invention compliant member 2375 may facilitate the engagement of tissue which is not flat, such as, for example tissue in the outer regions of the axilla. According to an embodiment of the invention compliant member 2375 may provide improved sealing characteristics between the skin and tissue chamber 2338, particularly where the skin is not flat. According to an embodiment of the invention compliant member 2375 may speed the acquisition of tissue in tissue chamber 2338, particularly where the skin is not flat. According to an embodiment of the invention compliant member 2375 may have a height of between approximately 0.15 inches and approximately 0.40 inches above chamber opening 2339 when compliant member 2375 is not compressed. According to an embodiment of the invention compliant member 2375 may have a height of approximately 0.25 inches above chamber opening 2339 when compliant member 2375 is not compressed. According to an embodiment of the invention alignment features 3352 may be positioned at a distance which facilitate appropriate placement of applicator 2320 during treatment. According to an embodiment of the invention alignment features 3352 may be positioned approximately 30.7 millimeters apart. According to an embodiment of the invention alignment features 3352 may be further positioned and may be designed to assist a physician in positioning applicator 2320 prior to the application of energy. According to an embodiment of the invention alignment features 3352 on disposable 2363 assist the user in properly positioning the applicator prior to treatment and in moving the applicator to the next treatment region during a procedure. According to an embodiment of the invention alignment features 3352 on disposable 2363, when used with marks or landmarks in a treatment region facilitate the creation of a continuous lesion. According to an embodiment of the invention alignment features 3352 may be used to align medical treatment device 2300 before suction is applied. According to an embodiment of the invention an outer edge of compliant member 2375 may assist a user in aligning medical treatment device 2300.
  • According to an embodiment of the invention compliant member 2375, which may also be referred to as a skirt or flexible skirt, may be manufactured from silicone. According to an embodiment of the invention compliant member 2375 may extend approximately 0.25″ from rigid surface 3500. According to an embodiment of the invention a counter sink or dovetail notch 2356 may be positioned in rigid disposable surface 3500 around the outer edge of chamber opening 2339 to assist in alignment of compliant member 2375. According to an embodiment of the invention the compliant member 2375 may have a durometer density rating (softness) of approximately A60 which may help compliant member 2375 to maintain its shape better while being easier to mold. According to an embodiment of the invention colorant may be used in compliant member 2375 to contrast with skin viewed through compliant member 2375, making it easier for user, such as a physician to distinguish between skin and a distal surface of compliant member 2375. According to an embodiment of the invention colorant may be used in compliant member 2375 to make it easier for user, such as a physician to distinguish between skin and an outer edge of compliant member 2375. According to an embodiment of the invention colorant may be used in compliant member 2375 to help a user distinguish an edge of compliant member 2375 from surrounding skin and assist in aligning of medical treatment device 2300. According to an embodiment of the invention the angle of compliant member 2375 relative to rigid surface 3500 may be approximately 53 degrees when compliant member 2375 is not compressed.
  • According to an embodiment of the invention disposable 2363 includes applicator chamber 2346. According to an embodiment of the invention disposable 2363 may include an applicator chamber 2346 which may be formed, at least in part, by tissue bio-barrier 2337. According to an embodiment of the invention disposable 2363 may include applicator bio-barrier 2332 (which may be, for example, a polyethylene film, available from Fisher Scientific), and vacuum passage 3333. According to an embodiment of the invention a counter bore may positioned between applicator bio-barrier 2332 and applicator chamber 2346.
  • According to an embodiment of the invention vacuum passage 3333 connects vacuum channel 3350 to tissue chamber 2338. According to an embodiment of the invention vacuum channel 3350 may also be referred to as a reservoir or vacuum reservoir. According to an embodiment of the invention vacuum connector 2328 is connected to vacuum passage 3333 through vacuum channel 3350. According to an embodiment of the invention vacuum channel 3350 may connect vacuum passages 3333 connect vacuum connector 2328 in tissue chamber 2338. According to an embodiment of the invention vacuum passages 3333 form a direct path to tissue interface surface 2336. According to an embodiment of the invention vacuum passages 3333 and vacuum channel 3350 may be adapted to restrict the movement of fluids from tissue chamber 2338 to applicator bio-barrier 2332. According to an embodiment of the invention vacuum connector 2328 may be positioned on the same side of disposable 2363 as applicator bio-barrier 2332. According to an embodiment of the invention applicator bio-barrier 2332 may be designed to prevent fluids from tissue chamber 2338 from reaching applicator chamber 2346, particularly when there is back pressure caused by, for example, a vacuum created in tissue chamber 2338 as tissue is pulled away from tissue interface surface 2336. According to an embodiment of the invention vacuum pressure may be used to support tissue acquisition in tissue chamber 2338. According to an embodiment of the invention vacuum pressure may be used to pull tissue into tissue chamber 2338. According to an embodiment of the invention vacuum pressure may be used to maintain tissue in tissue chamber 2338. According to an embodiment of the invention vacuum channel 2350 may surround tissue interface surface 2336. According to an embodiment of the invention applicator bio-barrier 2332 may be positioned between vacuum passages 3333 and applicator chamber 2346. According to an embodiment of the invention applicator bio-barrier 2332 may be a membrane which may be adapted to be permeable to air but substantially impermeable to biological fluids such as, for example, blood and sweat. According to an embodiment of the invention applicator bio-barrier 2332 may be a hydrophobic membrane filter. According to an embodiment of the invention applicator bio-barrier 2332 may be made of polyethylene film, nylon or other suitable materials. According to an embodiment of the invention applicator bio-barrier 2332 may include pores having sizes sufficient to pass enough air to substantially equalize the vacuum pressure in applicator chamber 2346 and in tissue chamber 2338 without passing biological fluids from tissue chamber 2338 to applicator chamber 2346. According to an embodiment of the invention applicator bio-barrier 2332 may include pores having sizes of approximately 0.45 micrometers. According to an embodiment of the invention when the vacuum is turned on, and before pressure is equalized, applicator bio-barrier 2332 may induce a minimal pressure drop between vacuum passages 3333 and the applicator chamber 2346. According to an embodiment of the invention applicator chamber 2346 and tissue chamber 2338 may be separated, at least in part, by tissue bio-barrier 2337. According to an embodiment of the invention tissue chamber 2338 may include tissue interface surface 2336 and chamber wall 2354.
  • According to an embodiment of the invention tissue chamber opening 2339 has dimensions which facilitate the acquisition of tissue. According to an embodiment of the invention tissue chamber 2339 may be sized to facilitate tissue acquisition while being large enough to prevent interference with energy radiated from waveguide antennas 2364 in antenna array 2355 when applicator 2320 is attached to disposable 2363. According to an embodiment of the invention a vacuum circuit 3341 may include vacuum passages 3333, vacuum channel 3350 and may encircle tissue chamber 3338. According to an embodiment of the invention vacuum channel 3350 may be positioned around tissue chamber 2338. According to an embodiment of the invention vacuum passage 3333 may be positioned around a proximal end of tissue chamber 2338. According to an embodiment of the invention vacuum passage 3333 may be positioned around a proximal end of tissue chamber 2338 between tissue bio-barrier 2337 and a proximal end of chamber wall 2354. According to an embodiment of the invention an opening to vacuum passage 3333 may be approximately 0.020 inches in height. According to an embodiment of the invention an opening to vacuum passage 3333 may be approximately 0.010 inches in height when disposable 2363 is attached to applicator 2320 and tissue bio-barrier 2337 is stretched into tissue chamber 2338 by a distal end of applicator 2320. According to an embodiment of the invention vacuum passage 3333 may have an opening height which is too small for tissue to invade when a vacuum is applied.
  • According to an embodiment of the invention disposable 2363 may be manufactured from a clear or substantially clear material to assist a user, such as a physician in viewing tissue engagement. According to an embodiment of the invention the disposable 2363 may have an outer angle to allow a user to see alignment features 3352 on compliant member 2375 to assist a user in aligning medical treatment device 2300. According to an embodiment of the invention an angle around the outside of disposable 2363 provides a user with a direct view of alignment features 3352. According to an embodiment of the invention tissue chamber 2338 may have dimensions of approximately 1.54 inches by approximately 0.7 inches. According to an embodiment of the invention the 4 corners of tissue chamber 2338 may have a radius of 0.1875 inches. According to an embodiment of the invention antenna array 2335 may include four antennas and may have dimensions of approximately 1.34 inches by approximately 0.628 inches. According to an embodiment of the invention the dimensions of the waveguide array 2335 and tissue chamber 2338 may be optimized to minimizing stray fields forming at the edges of waveguide array 2335 as well as optimizing the effective cooling area of tissue interface surface 2336. According to an embodiment of the invention tissue chamber 2338 may be optimized to facilitate tissue acquisition without adversely impacting cooling or energy transmission.
  • FIG. 16 is a perspective view of antenna array 2355 according to an embodiment of the invention. According to an embodiment of the invention antenna array 2355 may include antenna cradle 2374. According to an embodiment of the invention antenna cradle 2374 may include reservoir inlet 2384 and antenna chamber 2377. According to an embodiment of the invention waveguide assembly 2358 may include one or more spacer 3391 (which may be, for example, copper shims) positioned between waveguide antennas 2364. According to an embodiment of the invention spacer 3391 may be positioned between waveguide antenna 2364 a and waveguide antenna 2364 b. According to an embodiment of the invention spacer 3391 may be positioned between waveguide antenna 2364 b and waveguide antenna 2364 c. According to an embodiment of the invention spacer 3391 may be positioned between waveguide antenna 2364 c and waveguide antenna 2364 d. According to an embodiment of the invention microwave energy may be supplied to each waveguide antenna through feed connectors 2388. According to an embodiment of the invention waveguide assembly 2358 may be held together by a waveguide assembly frame 2353. According to an embodiment of the invention waveguide assembly frame 2353 may include feed brackets 2351 and assembly bolts 2349. According to an embodiment of the invention antenna array 2355 may include antenna cradle 2374 and least one waveguide antenna 2364. According to an embodiment of the invention antenna array 2355 may include one or more spacer 3391. According to an embodiment of the invention antenna array 2355 may include four waveguide antennas 2364 a, 2364 b, 2364 c and 2364 d. According to an embodiment of the invention the heights of waveguide antennas 2364 in antenna array 2355 may be staggered to facilitate access to feed connectors 2388. According to an embodiment of the invention one or more waveguide antenna 2364 in antenna array 2355 may include tuning element 2390.
  • FIG. 17 is an end view of a portion of antenna array 2355 according to an embodiment of the invention. FIG. 18 is a cutaway side view of a portion antenna array 2355 according to an embodiment of the invention. FIG. 19 is a cutaway side view of a portion antenna array 2355 according to an embodiment of the invention. According to an embodiment of the invention antenna array 2355 includes coolant chambers 2360 (for example coolant chambers 2360 a, 2360 b, 2360 c and 2360 d), intermediate scattering elements 3393, separation ribs 2393 and scattering elements 2378 (for example scattering elements 2378 a, 2378 b, 2378 c and 2378 d). According to an embodiment of the invention scattering elements 2378 may also be referred to as central scattering elements. According to an embodiment of the invention coolant chambers 2360 a-2360 d may be located beneath waveguide antenna 2364 a-2364 d. According to an embodiment of the invention coolant chambers 2360 may include separation ribs 2393 on either side of antenna array 2355 and intermediate scattering elements 3393 between antennas 2364. According to an embodiment of the invention an intermediate scattering element 3393 may be positioned between waveguide antenna 2364 a and waveguide antenna 2364 b. According to an embodiment of the invention an intermediate scattering element 3393 may be positioned between waveguide antenna 2364 b and waveguide antenna 2364 c. According to an embodiment of the invention an intermediate scattering element 3393 may be positioned between waveguide antenna 2364 c and waveguide antenna 2364 d. According to an embodiment of the invention cooling fluid flowing through coolant chambers 2360 may have a flow rate of between approximately 200 milliliters per minute and approximately 450 milliliters per minute and preferably approximately 430 milliliters per minute. According to an embodiment of the invention coolant chambers 2360 may be designed to ensure that the flow rate through each coolant chamber 2360 is substantially the same. According to an embodiment of the invention coolant the flow rate of cooling fluid through coolant chamber 2360 a is the same as the flow rate of cooling fluid through coolant chamber 2360 b. According to an embodiment of the invention coolant the flow rate of cooling fluid through coolant chamber 2360 a is the same as the flow rate of cooling fluid through coolant chambers 2360 b, 2360 c and 2360 d. According to an embodiment of the invention cooling fluid flowing through coolant chamber 2360 may have a temperature of between approximately 8 degrees centigrade and approximately 22 degrees centigrade and preferably approximately 15 degrees centigrade. According to an embodiment of the invention coolant chambers 2360 may be positioned between an aperture of waveguide antenna 2364 cooling plate 2340. According to an embodiment of the invention scattering elements 2378 may extend into at least a portion of coolant chambers 2360. According to an embodiment of the invention scattering elements 2378 may extend through coolant chambers 2360. According to an embodiment of the invention scattering elements 2378 and intermediate scattering elements 3393 may extend through coolant chambers 2360 to contact a proximal surface of cooling plate 2340. According to an embodiment of the invention elements of coolant chamber 2360 may be smoothed or rounded to promote laminar fluid flow through coolant chambers 2360. According to an embodiment of the invention elements of coolant chambers 2360 may be smoothed to reduce the generation of air bubbles in coolant chamber 2360. According to an embodiment of the invention scattering elements 2378 which extend into coolant chambers 2360 may be rounded to promote laminar flow and prevent the buildup of bubbles in coolant chamber 2360. According to an embodiment of the invention scattering elements 2378 may be formed in the shape of ovals or racetracks. According to an embodiment of the invention square edges or sharp corners in coolant chamber 2360 may result in undesirable flow characteristics, including the generation of air bubbles, as cooling fluid moves through coolant chamber 2360. According to an embodiment of the invention intermediate scattering elements 3393 may be positioned between separate individual coolant chambers 2360. According to an embodiment of the invention intermediate scattering elements 3393 may be positioned such that they facilitate equalized cooling across cooling plate 2340. According to an embodiment of the invention intermediate scattering elements 3393 may be sized such that they have a width which is equal to or less than the separation distance between apertures of waveguide antennas 2364. According to an embodiment of the invention intermediate scattering elements 3393 may be sized and positioned such that they are not positioned an aperture of waveguide antenna 2364. According to an embodiment of the invention intermediate scattering elements 3393 may be sized and positioned such that they modify a microwave field as it travels through coolant chamber 2360. According to an embodiment of the invention intermediate scattering elements 3393 may be sized and positioned such that they modify a microwave field radiated from waveguide antenna 2364. According to an embodiment of the invention intermediate scattering elements 3393 may be sized and positioned such that they spread out a microwave field as it travels through coolant chamber 2360. According to an embodiment of the invention intermediate scattering elements 3393 may cause disruption or perturbation of microwave energy radiated from waveguide antenna 2364. According to an embodiment of the invention intermediate scattering elements 3393 may be made of materials which will not rust or degrade in cooling fluid. According to an embodiment of the invention intermediate scattering elements 3393 may be made of materials which improve the SAR pattern in tissue. According to an embodiment of the invention intermediate scattering elements 3393 may be made of materials, such as dielectric materials, which are used to form scattering elements 2378. According to an embodiment of the invention FIGS. 17 through 19 may also include waveguide assembly 2358, feed connectors 2388, antenna chamber 2377, spacers 3391, cradle channels 2389 and antenna cradle 2374.
  • According to an embodiment of the invention intermediate scattering elements 3393 may be positioned between waveguide antennas 2364. According to an embodiment of the invention the size and shape of the intermediate scattering elements 3393 may be designed to optimize the size and shape of lesions developed in the skin between waveguide antennas 2364. According to an embodiment of the invention intermediate scattering elements 3393 may make lesions created in tissue between waveguide antennas 2364 larger and more spread out. According to an embodiment of the invention intermediate scattering elements 3393 may make lesions created in tissue between waveguide antennas 2364 narrower. According to an embodiment of the invention intermediate scattering elements 3393 may have an optimal length which is shorter than the length of scattering elements 2378. According to an embodiment of the invention scattering elements 2378 may be approximately 7 millimeters in length. According to an embodiment of the invention intermediate scattering elements 3393 may have an optimal length which is approximately 6.8 millimeters. According to an embodiment of the invention intermediate scattering elements 3393 may be manufactured from, for example, alumina. According to an embodiment of the invention intermediate scattering elements 3393 may be manufactured from, for example, a material which is approximately 96% alumina. According to an embodiment of the invention intermediate scattering elements 3393 may be manufactured from, for example, silicone. According to an embodiment of the invention the intermediate scattering elements 3393 may be manufactured from a material having the same dielectric constant as scattering elements 2378. According to an embodiment of the invention the intermediate scattering elements 3393 may be manufactured from a material having approximately the same dielectric constant as scattering elements 2378. According to an embodiment of the invention intermediate scattering elements 3393 may be manufactured from a material having a dielectric constant of approximately 10. According to an embodiment of the invention intermediate scattering elements 3393 may be manufactured from a material having a dielectric constant of approximately 3. According to an embodiment of the invention increasing the dielectric constant of intermediate scattering element 3393 may reduce the size of a lesion created in skin between waveguide antennas 2364. According to an embodiment of the invention intermediate scattering elements 3393 may be inserted into tongue and groove slots between wave antennas 2364. According to an embodiment of the invention thermocouples may be positioned beneath one or more of intermediate scattering elements 3393. According to an embodiment of the invention thermocouples may be positioned each of intermediate scattering elements 3393.
  • FIGS. 20, 21 and 22 are simplified cutaway views of a medical treatment device 2300 with tissue engaged according to an embodiment of the invention. According to an embodiment of the invention skin 1307 is engaged in treatment device 2300. According to an embodiment of the invention dermis 1305 and hypodermis 1303 are engaged in medical treatment device 2300. According to an embodiment of the invention skin surface 1306 is engaged in medical treatment device 2300 such that skin surface 1306 is in thermal contact with at least a portion of cooling plate 2340. According to an embodiment of the invention skin surface 1306 is engaged in medical treatment device 2300 such that skin surface 1306 is in contact with at least a portion of tissue interface 2336. According to an embodiment of the invention a vacuum pressure may be used to elevate dermis 1305 and hypodermis 1303, separating dermis 1305 and hypodermis 1303 from muscle 1301. According to an embodiment of the invention vacuum pressure may be used to elevate dermis 1305 and hypodermis 1303, separating dermis 1305 and hypodermis 1303 from muscle 1301 to, for example, protect muscle 1301 by limiting or eliminating the electromagnetic energy which reaches muscle 1301. According to an embodiment of the invention waveguide assembly 2358 may include one or more waveguide antennas 2364. According to an embodiment of the invention electromagnetic energy, such as, for example, microwave energy may be radiated into dermis 1305 by medical treatment device 2300. According to an embodiment of the invention medical treatment device 2300 may include coolant chamber 2360 and cooling plate 2340. According to an embodiment of the invention a peak which may be, for example, a peak SAR, peak power loss density or peak temperature, is generated in first tissue region 1309. According to an embodiment of the invention first tissue region 1309 may represent a lesion created by energy, such as, for example, microwave energy radiated from medical treatment device 2300. According to an embodiment of the invention first tissue region 1309 may represent a lesion created by microwave energy radiated from one or more of waveguide antennas 2364. According to an embodiment of the invention first tissue region 1309 may be initiated in skin 1307 between first waveguide antenna 2364 and a second waveguide antenna 2364. According to an embodiment of the invention first tissue region 1309 may be initiated in skin 1307 between first waveguide antenna 2364 a and a second waveguide antenna 2364 b. According to an embodiment of the invention first tissue region 1309 may be initiated in skin 1307 underlying intermediate scattering element 3393. According to an embodiment of the invention a reduced magnitude which may be, for example, a reduced SAR, reduced power loss density or reduced temperature, is generated in second tissue region 1311 with further reduced magnitudes in third tissue region 1313 and fourth tissue region 1315. As illustrated in FIGS. 20 through 22, dermis 1305 is separated from hypodermis 1303 by interface 1308. As illustrated in FIGS. 20 through 22 interface 1308 may be idealized as a substantially straight line for the purposes of simplified illustration however in actual tissue, interface 1308 may be a non-linear, non-continuous, rough interface which may also include many tissue structures and groups of tissue structures which cross and interrupt tissue interface 1308. According to an embodiment of the invention electromagnetic radiation may be radiated at a frequency of, for example, between 5 and 6.5 GHz. According to an embodiment of the invention electromagnetic radiation may be radiated at a frequency of, for example, approximately 5.8 GHz. According to an embodiment of the invention scattering element 2378 may be located in coolant chamber 2360 and intermediate scattering elements 3393 may be located between coolant chambers 2360. According to an embodiment of the invention scattering element 2378 and intermediate scattering elements 3393 may be used to, for example, spread and flatten first tissue region 1309. According to an embodiment of the invention scattering element 2378 and intermediate scattering elements 3393 may be used to, for example, spread and flatten a region, such as first tissue region 1309, of peak SAR in tissue. According to an embodiment of the invention scattering element 2378 and intermediate scattering elements 3393 may be used to, for example, spread and flatten a region, such as first tissue region 1309, of peak power loss density in tissue. According to an embodiment of the invention scattering element 2378 and intermediate scattering elements 3393 may be used to, for example, spread and flatten a region, such as first tissue region 1309, of peak temperature in tissue. According to an embodiment of the invention scattering element 2378 and scattering elements 3393 may be used to, for example, spread and flatten lesions formed in first tissue region 1309. According to an embodiment of the invention the creation of lesions, such as for example, a lesion in tissue region 1309 may be used to treat the skin of patients. According to an embodiment of the invention the creation of lesions, such as for example, a lesion in tissue region 1309 may be used to damage or destroy structures, such as, for example, sweat glands in the skin of a patient.
  • FIG. 23 is a graphical illustration of a pattern of lesions in tissue according to an embodiment of the invention. According to an embodiment of the invention lesions may be created in a predetermined order, such as, for example A-B-C-D where: A represents a lesion initiated directly under waveguide antenna 2364 a; B represents a lesion initiated directly under waveguide antenna 2364 b; C represents a lesion initiated directly under waveguide antenna 2364 c; D represents a lesion initiated directly under waveguide antenna 2364 d. According to an embodiment of the invention lesions may be created in a predetermined order such as, for example, A-AB-B-BC-C-CD-D where: A represents a lesion initiated directly under waveguide antenna 2364 a; AB represents a lesion initiated under the intersection between waveguide antenna 2364 a and waveguide antenna 2364 b; B represents a lesion initiated directly under waveguide antenna 2364 b; BC represents a lesion initiated under the intersection between waveguide antenna 2364 b and waveguide antenna 2364 c; C represents a lesion initiated directly under waveguide antenna 2364 c; CD represents a lesion initiated under the intersection between waveguide antenna 2364 c and waveguide antenna 2364 d; and D represents a lesion initiated directly under waveguide antenna 2364 d. According to an embodiment of the invention a lesion AB may be created between waveguide antenna 2364 a and waveguide antenna 2364 b, by driving waveguide antenna 2364 a and waveguide antenna 2364 b simultaneously in phase and with a balanced output from each antenna. According to an embodiment of the invention a lesion BC may be created between waveguide antenna 2364 b and waveguide antenna 2364 c, by driving waveguide antenna 2364 b and waveguide antenna 2364 c simultaneously in phase and with a balanced output from each waveguide antenna. According to an embodiment of the invention a lesion CD may be created between waveguide antenna 2364 c and waveguide antenna 2364 d, by driving waveguide antenna 2364 c and waveguide antenna 2364 d simultaneously in phase and with a balanced output from each waveguide antenna.
  • FIG. 24 is a treatment template 2483 according to an embodiment of the invention. According to an embodiment of the invention treatment template 2483 may include axilla outline 2497, anesthesia injection sites 2485, landmark alignment marks 2497, device alignment points 2498 and device alignment lines 2499. According to an embodiment of the invention axilla outline 2497 may be matched to the hair bearing area of a patient to select an appropriate treatment template 2483. According to an embodiment of the invention anesthesia injection sites 2485 may be used to identify appropriate points in the axilla for the injection of anesthesia. According to an embodiment of the invention landmark alignment marks may be used to align treatment template 2483 to landmarks, such as, for example, tattoos or moles on the axilla. According to an embodiment of the invention device alignment points 2498 may be used in conjunction with alignment features 3352 to properly align medical treatment device 2300. According to an embodiment of the invention device alignment lines 2499 may be used in conjunction with an outer edge of compliant member 2375 to properly align medical treatment device 2300. According to an embodiment of the invention treatment template 2384 provides guidance and placement information for medical treatment device 2300 in matrix format.
  • According to an embodiment of the invention, a medical device disposable may include: a tissue chamber may have a tissue opening at a distal end and a rigid surface surrounding the tissue opening; an applicator chamber; a flexible bio-barrier at a proximal end of the tissue chamber the flexible bio-barrier separating the tissue chamber and the applicator chamber, a portion of the flexible bio-barrier forming a tissue contacting surface; a compliant member surrounding the tissue opening, the compliant member may have a proximal opening adjacent the tissue opening and a distal opening, wherein the distal opening may be larger than the proximal opening.
  • According to an embodiment of the invention the medical device disposable compliant member may be positioned at an angle of approximately fifty-three degrees with respect to the rigid surface. According to an embodiment of the invention the compliant member may include a wall connecting the proximal opening and the distal opening and the wall may be angled approximately fifty-three degrees with respect to the rigid surface. According to an embodiment of the invention the compliant member may further include an outer rim positioned around the distal opening. According to an embodiment of the invention: the outer rim may extend a distance of approximately 0.033 inches from the distal opening; the compliant member may have a height of approximately 0.25 inches; the tissue opening may have a long axis and a short axis, the tissue opening long axis may be approximately 1.875 inches and the tissue opening short axis may be approximately 1.055 inches; the distal opening in the compliant member may have a long axis and a short axis, the distal opening long axis may be approximately 2.429 inches and the distal opening short axis may be approximately 1.609 inches; the tissue contact surface may have a long axis and a short axis, the long axis may be approximately 1.54 inches and the short axis may be approximately 0.700 inches. According to an embodiment of the invention the wall may be substantially straight. According to an embodiment of the invention the compliant member may include one or more alignment marks, at least one of the alignment marks may be positioned on a long side of the compliant member. According to an embodiment of the invention the alignment marks may be positioned on a wall of the skirt and may extend from approximately the rim toward the tissue opening. According to an embodiment of the invention the alignment marks may move with respect to an applicator positioned in the applicator chamber when the medical device disposable is pressed against tissue with sufficient pressure to compress the compliant member. According to an embodiment of the invention the wall may have a thickness of approximately 0.050 inches. According to an embodiment of the invention the tissue chamber may include a chamber wall extending from the tissue opening to approximately the tissue contact surface, the wall may also include a substantially smooth, radiused surface. According to an embodiment of the invention the radiused surface may have a radius of approximately three-sixteenths of an inch. According to an embodiment of the invention the compliant member may have durometer density rating of approximately A60.
  • According to an embodiment of the invention, a medical device disposable may include: a tissue chamber including a tissue contact surface at a proximal end of the tissue chamber and a tissue opening at a distal end of the tissue chamber; an applicator chamber; a flexible bio-barrier at a proximal end of the tissue chamber the flexible bio-barrier separating the tissue chamber and the applicator chamber, the flexible bio-barrier forming at least a portion of the tissue contact surface; a vacuum port; a vacuum circuit connecting the tissue chamber, the applicator chamber and the vacuum port, the vacuum circuit including a vacuum passage.
  • According to an embodiment of the invention the vacuum circuit may include: a vacuum passage positioned around the tissue contact surface; a vacuum channel positioned around the vacuum passage, the vacuum channel positioned between the vacuum passage and the vacuum port; an applicator bio-barrier positioned between the vacuum port and the applicator chamber, the applicator bio-barrier being substantially permeable to air and substantially impermeable to fluids. According to an embodiment of the invention the vacuum passage may completely surround the tissue interface surface. According to an embodiment of the invention the vacuum passage may substantially surrounds the tissue interface surface. According to an embodiment of the invention the vacuum passage may be positioned in a wall of the tissue chamber adjacent the tissue contact surface. According to an embodiment of the invention vacuum port may be connected to a vacuum tube. According to an embodiment of the invention the vacuum tube may include a generator bio-barrier. According to an embodiment of the invention the generator bio-barrier may be substantially permeable to air and being substantially impermeable to fluids. According to an embodiment of the invention the vacuum channel may include a well region adapted to collect fluids from the tissue chamber. According to an embodiment of the invention a compliant member may surround the tissue opening, the compliant member may have a proximal opening adjacent the tissue opening and a distal opening, wherein the distal opening may be larger than the proximal opening. According to an embodiment of the invention the vacuum passage may be an opening between a wall of the tissue chamber and the tissue bio-barrier. According to an embodiment of the invention the vacuum passage may be approximately 0.020″ inches wide. According to an embodiment of the invention the vacuum passage may be greater than approximately 0.010″ inches when the medical device disposable may be attached to an applicator. According to an embodiment of the invention the tissue surface may have an area greater than an outer area of an antenna array in an applicator affixed to the medical device disposable. According to an embodiment of the invention the tissue surface may have an area greater than an aperture area of an antenna array in an applicator affixed to the medical device disposable.
  • According to an embodiment of the invention a method of creating a lesion in skin is described, the method including the steps of: positioning an apparatus including a plurality of antennas adjacent a skin surface; supplying energy to a first antenna at a first power level for a first time period; supplying energy to a second antenna at a second power level for a second time period; supplying energy simultaneously to both the first antenna and the second antenna for a third time period, wherein, during the third time period the energy may be supplied to the first antenna at a third power level and the energy may be supplied to the second antenna at a fourth power level. According to an embodiment of the invention the energy supplied to the first antenna may be in phase with the energy supplied to the second antenna. According to an embodiment of the invention the energy supplied to the first antenna may be phase shifted from the energy supplied to the second antenna. According to an embodiment of the invention the energy supplied to the first antenna may be phase shifted approximately one hundred eighty degrees from the energy supplied to the second antenna. According to an embodiment of the invention the energy supplied to the first antenna may be phase shifted between one and one hundred eighty degrees from the energy supplied to the second antenna. According to an embodiment of the invention the energy output from the first antenna may be substantially in phase with energy output from the second antenna. According to an embodiment of the invention the energy supplied to the first antenna may be phase shifted from the energy supplied to the second antenna, the phase shift being sufficient to cause energy output from the first antenna to be in phase with energy output from the second antenna. According to an embodiment of the invention the energy supplied to the first and second antennas may be microwave energy having a frequency of approximately 5.8 GHz. According to an embodiment of the invention the first and second antennas may be microwave antennas. According to an embodiment of the invention the first and second antennas may be waveguide antennas. According to an embodiment of the invention the first and the second power levels may be substantially equal. According to an embodiment of the invention the first power level may be greater than the second power level. According to an embodiment of the invention the power emitted by the first antenna may be substantially equal to power emitted by the second antenna.
  • According to an embodiment of the invention a medical device applicator may include: an antenna array including at least two antenna apertures; at least one intermediate scattering element positioned outside the apertures wherein the at least one intermediate scattering element may be further positioned between the apertures. According to an embodiment of the invention each of the apertures may be substantially rectangular in shape, the apertures including a long axis and a short axis. According to an embodiment of the invention each of the intermediate scattering elements may include a long axis and a short axis wherein the long axis of the at least one intermediate scattering element may be substantially parallel to the long axis of the aperture. According to an embodiment of the invention the medical device applicator may include a cooling plate and the intermediate scattering element may be positioned between the antenna apertures and the cooling plate. According to an embodiment of the invention the medical device applicator may further include one or more coolant chambers positioned between the cooling plate and the antenna aperture. According to an embodiment of the invention the medical device applicator may include at least two central scattering elements positioned under the aperture wherein the at least one intermediate scattering element may be positioned between the central scattering elements. According to an embodiment of the invention the central scattering elements may be positioned substantially in a center of one of the antenna apertures. According to an embodiment of the invention the long axis of the intermediate scattering element may be shorter than the longest dimension of the central scattering element. According to an embodiment of the invention the intermediate scattering element may be manufactured from a material which may have the same dielectric constant as the central scattering element. According to an embodiment of the invention the intermediate scattering element may be made from alumina. According to an embodiment of the invention the intermediate scattering element may be made from a material which may be more than 90 percent alumina. According to an embodiment of the invention the intermediate scattering element may be made from a material which may be approximately 96 percent alumina. According to an embodiment of the invention the intermediate scattering element may be made from, for example silicone. According to an embodiment of the invention one or more temperature measurement devices may be positioned on the cooling plate under the intermediate scattering element. According to an embodiment of the invention the one or more temperature measurement device may be one or more thermocouples.
  • According to an embodiment of the invention a medical device applicator may include at least a first and a second waveguide antenna and at least a first electrically conductive shim positioned between the waveguide antennas. According to an embodiment of the invention each of the waveguide antennas may include: a dielectric core having four sides; metal plating on three sides of the dielectric core, the fourth side of the dielectric core forming an antenna aperture. According to an embodiment of the invention the electrically conductive shim may be copper. According to an embodiment of the invention the electrically conductive shim may be approximately 0.025 inches thick. According to an embodiment of the invention the electrically conductive shim may be positioned between the first and second waveguide antennas such that an edge of the electrically conductive shim may be adjacent the antenna apertures. According to an embodiment of the invention an intermediate scattering element may be positioned under the conductive shim. According to an embodiment of the invention central scattering elements may be positioned under the antenna apertures. According to an embodiment of the invention the medical device applicator may include a cooling plate. According to an embodiment of the invention the intermediate scattering element and the central scattering element may be positioned between the antenna apertures and the cooling plate. According to an embodiment of the invention the medical device applicator may include a coolant chamber positioned between the antenna apertures and the cooling plate. According to an embodiment of the invention the medical device applicator may include temperature sensors positioned on the cooling plate.

Claims (11)

What is claimed is:
1. A system for creating a lesion in skin, said system comprising:
an apparatus including a plurality of waveguide antennas, including at least a first, second, third and fourth waveguide antenna;
a control system, wherein said control system:
supplies energy to said first waveguide antenna at a first power level for a first time period;
supplies energy to said second waveguide antenna at a second power level for a second time period; and
supplies energy simultaneously to both said first waveguide antenna and said second waveguide antenna for a third time period, wherein, during said third time period said energy is supplied to said first waveguide antenna at a third power level and said energy is supplied to said second waveguide antenna at a fourth power level.
2. The system of claim 1 wherein said energy supplied to said first waveguide antenna is in phase with said energy supplied to said second waveguide antenna.
3. The system of claim 2 wherein said energy supplied to said first waveguide antenna is phase shifted from said energy applied to said second waveguide antenna.
4. The system of claim 3 wherein said energy supplied to said first waveguide antenna is phase shifted approximately 180 degrees from said energy applied to said second waveguide antenna.
5. The system of claim 4 wherein said energy supplied to said first waveguide antenna is phase shifted between approximately 1 degree and 180 degrees from said energy applied to said second waveguide antenna.
6. The system of claim 5 wherein energy output from said first waveguide antenna is substantially in phase with energy output from said second waveguide antenna.
7. The system of claim 3 wherein said energy supplied to said first waveguide antenna is phase shifted from said energy applied to said second waveguide antenna, said phase shift being sufficient to cause energy output from said first waveguide antenna to be in phase with energy output from said second waveguide antenna.
8. The system of claim 1 wherein said energy supplied to said first and second waveguide antennas is microwave energy.
9. The system of claim 7 wherein said first and second power levels are substantially equal.
10. The system of claim 9 wherein said first power level is greater than said second power level.
11. The system of claim I wherein energy output from said first waveguide antenna is substantially equal to energy output from said second waveguide antenna.
US15/005,892 2007-04-19 2016-01-25 Systems, apparatus, methods and procedures for the noninvasive treatment of tissue using microwave energy Abandoned US20160135888A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US15/005,892 US20160135888A1 (en) 2007-04-19 2016-01-25 Systems, apparatus, methods and procedures for the noninvasive treatment of tissue using microwave energy

Applications Claiming Priority (14)

Application Number Priority Date Filing Date Title
US91289907P 2007-04-19 2007-04-19
US1327407P 2007-12-12 2007-12-12
US4593708P 2008-04-17 2008-04-17
PCT/US2008/060929 WO2009075904A1 (en) 2007-04-19 2008-04-18 Methods, devices, and systems for non-invasive delivery of microwave therapy
PCT/US2008/060935 WO2008131302A2 (en) 2007-04-19 2008-04-18 Methods and apparatus for reducing sweat production
PCT/US2008/060922 WO2009075903A1 (en) 2007-04-19 2008-04-18 Systems and methods for creating an effect using microwave energy to specified tissue
PCT/US2008/060940 WO2008131306A1 (en) 2007-04-19 2008-04-18 Systems and methods for creating an effect using microwave energy to specified tissue
US12/107,025 US9427285B2 (en) 2007-04-19 2008-04-21 Systems and methods for creating an effect using microwave energy to specified tissue
US19694808P 2008-10-22 2008-10-22
PCT/US2008/013650 WO2009075879A1 (en) 2007-12-12 2008-12-12 Systems, apparatus, methods and procedures for the noninvasive treatment of tissue using microwave energy
US20831509P 2009-02-23 2009-02-23
PCT/US2009/002403 WO2009128940A1 (en) 2008-04-17 2009-04-17 Systems, apparatus, methods and procedures for the noninvasive treatment of tissue using microwave energy
US98816510A 2010-10-15 2010-10-15
US15/005,892 US20160135888A1 (en) 2007-04-19 2016-01-25 Systems, apparatus, methods and procedures for the noninvasive treatment of tissue using microwave energy

Related Parent Applications (2)

Application Number Title Priority Date Filing Date
PCT/US2009/002403 Continuation WO2009128940A1 (en) 2007-04-19 2009-04-17 Systems, apparatus, methods and procedures for the noninvasive treatment of tissue using microwave energy
US12/988,165 Continuation US9241763B2 (en) 2007-04-19 2009-04-17 Systems, apparatus, methods and procedures for the noninvasive treatment of tissue using microwave energy

Publications (1)

Publication Number Publication Date
US20160135888A1 true US20160135888A1 (en) 2016-05-19

Family

ID=53539977

Family Applications (2)

Application Number Title Priority Date Filing Date
US12/988,165 Active 2030-03-11 US9241763B2 (en) 2007-04-19 2009-04-17 Systems, apparatus, methods and procedures for the noninvasive treatment of tissue using microwave energy
US15/005,892 Abandoned US20160135888A1 (en) 2007-04-19 2016-01-25 Systems, apparatus, methods and procedures for the noninvasive treatment of tissue using microwave energy

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US12/988,165 Active 2030-03-11 US9241763B2 (en) 2007-04-19 2009-04-17 Systems, apparatus, methods and procedures for the noninvasive treatment of tissue using microwave energy

Country Status (3)

Country Link
US (2) US9241763B2 (en)
EP (2) EP2271276A4 (en)
WO (1) WO2009128940A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10166072B2 (en) 2007-04-19 2019-01-01 Miradry, Inc. Systems and methods for creating an effect using microwave energy to specified tissue
US10321954B2 (en) 2011-08-01 2019-06-18 Miradry, Inc. Applicator and tissue interface module for dermatological device
US10463429B2 (en) 2007-04-19 2019-11-05 Miradry, Inc. Methods, devices, and systems for non-invasive delivery of microwave therapy
US10624696B2 (en) 2007-04-19 2020-04-21 Miradry, Inc. Systems and methods for creating an effect using microwave energy to specified tissue

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6104959A (en) 1997-07-31 2000-08-15 Microwave Medical Corp. Method and apparatus for treating subcutaneous histological features
CN110522505B (en) * 2002-03-15 2023-04-25 总医院公司 System for selective destruction of adipose tissue by controlled cooling
US8840608B2 (en) 2002-03-15 2014-09-23 The General Hospital Corporation Methods and devices for selective disruption of fatty tissue by controlled cooling
US9132031B2 (en) 2006-09-26 2015-09-15 Zeltiq Aesthetics, Inc. Cooling device having a plurality of controllable cooling elements to provide a predetermined cooling profile
US8192474B2 (en) 2006-09-26 2012-06-05 Zeltiq Aesthetics, Inc. Tissue treatment methods
US9149331B2 (en) * 2007-04-19 2015-10-06 Miramar Labs, Inc. Methods and apparatus for reducing sweat production
US20080287839A1 (en) 2007-05-18 2008-11-20 Juniper Medical, Inc. Method of enhanced removal of heat from subcutaneous lipid-rich cells and treatment apparatus having an actuator
US8523927B2 (en) 2007-07-13 2013-09-03 Zeltiq Aesthetics, Inc. System for treating lipid-rich regions
US8285390B2 (en) 2007-08-21 2012-10-09 Zeltiq Aesthetics, Inc. Monitoring the cooling of subcutaneous lipid-rich cells, such as the cooling of adipose tissue
AU2008335715B2 (en) * 2007-12-12 2014-01-23 Miradry, Inc. Systems, apparatus, methods and procedures for the noninvasive treatment of tissue using microwave energy
ES2471971T3 (en) 2007-12-12 2014-06-27 Miramar Labs, Inc. System and apparatus for non-invasive treatment of tissue using microwave energy
US8603073B2 (en) 2008-12-17 2013-12-10 Zeltiq Aesthetics, Inc. Systems and methods with interrupt/resume capabilities for treating subcutaneous lipid-rich cells
KR101871659B1 (en) 2009-04-30 2018-08-02 젤티크 애스세틱스, 인코포레이티드. Device, system and method of removing heat from subcutaneous lipid-rich cells
US8906007B2 (en) 2009-09-28 2014-12-09 Covidien Lp Electrosurgical devices, directional reflector assemblies coupleable thereto, and electrosurgical systems including same
US8394092B2 (en) * 2009-11-17 2013-03-12 Vivant Medical, Inc. Electromagnetic energy delivery devices including an energy applicator array and electrosurgical systems including same
WO2011091431A1 (en) 2010-01-25 2011-07-28 Zeltiq Aesthetics, Inc. Home-use applicators for non-invasively removing heat from subcutaneous lipid-rich cells via phase change coolants, and associated devices, systems and methods
US8676338B2 (en) 2010-07-20 2014-03-18 Zeltiq Aesthetics, Inc. Combined modality treatment systems, methods and apparatus for body contouring applications
WO2012103242A1 (en) 2011-01-25 2012-08-02 Zeltiq Aesthetics, Inc. Devices, application systems and methods with localized heat flux zones for removing heat from subcutaneous lipid-rich cells
ES2648875T3 (en) * 2011-08-01 2018-01-08 Miramar Labs, Inc. Applicator and tissue interface module for dermatological device
ES2652502T3 (en) * 2011-08-01 2018-02-02 Miramar Labs, Inc. Applicator and tissue interface module for dermatological device
US9907612B2 (en) * 2011-09-06 2018-03-06 Solta Medical, Inc. Cooled medical handpiece
JP2013143575A (en) * 2012-01-06 2013-07-22 Fujitsu Mobile Communications Ltd Radio communication terminal device and radio communication terminal device control method
US8943744B2 (en) * 2012-02-17 2015-02-03 Nathaniel L. Cohen Apparatus for using microwave energy for insect and pest control and methods thereof
CN104135957B (en) * 2012-04-20 2017-04-26 奥林巴斯株式会社 surgical device
US9844460B2 (en) 2013-03-14 2017-12-19 Zeltiq Aesthetics, Inc. Treatment systems with fluid mixing systems and fluid-cooled applicators and methods of using the same
US9545523B2 (en) 2013-03-14 2017-01-17 Zeltiq Aesthetics, Inc. Multi-modality treatment systems, methods and apparatus for altering subcutaneous lipid-rich tissue
WO2015013502A2 (en) 2013-07-24 2015-01-29 Miramar Labs, Inc. Apparatus and methods for the treatment of tissue using microwave energy
EP3099259A1 (en) 2014-01-31 2016-12-07 Zeltiq Aesthetics, Inc. Treatment systems and methods for affecting glands and other targeted structures
US10675176B1 (en) 2014-03-19 2020-06-09 Zeltiq Aesthetics, Inc. Treatment systems, devices, and methods for cooling targeted tissue
USD777338S1 (en) 2014-03-20 2017-01-24 Zeltiq Aesthetics, Inc. Cryotherapy applicator for cooling tissue
US10952891B1 (en) 2014-05-13 2021-03-23 Zeltiq Aesthetics, Inc. Treatment systems with adjustable gap applicators and methods for cooling tissue
US10935174B2 (en) 2014-08-19 2021-03-02 Zeltiq Aesthetics, Inc. Stress relief couplings for cryotherapy apparatuses
US10568759B2 (en) 2014-08-19 2020-02-25 Zeltiq Aesthetics, Inc. Treatment systems, small volume applicators, and methods for treating submental tissue
WO2017070112A1 (en) 2015-10-19 2017-04-27 Zeltiq Aesthetics, Inc. Vascular treatment systems, cooling devices, and methods for cooling vascular structures
EP3399950A1 (en) 2016-01-07 2018-11-14 Zeltiq Aesthetics, Inc. Temperature-dependent adhesion between applicator and skin during cooling of tissue
US10765552B2 (en) 2016-02-18 2020-09-08 Zeltiq Aesthetics, Inc. Cooling cup applicators with contoured heads and liner assemblies
AU2017248823B2 (en) 2016-04-14 2022-05-12 Hologic, Inc. Tissue localization device and method of use thereof
US10682297B2 (en) 2016-05-10 2020-06-16 Zeltiq Aesthetics, Inc. Liposomes, emulsions, and methods for cryotherapy
US10555831B2 (en) 2016-05-10 2020-02-11 Zeltiq Aesthetics, Inc. Hydrogel substances and methods of cryotherapy
US11382790B2 (en) 2016-05-10 2022-07-12 Zeltiq Aesthetics, Inc. Skin freezing systems for treating acne and skin conditions
US11896823B2 (en) 2017-04-04 2024-02-13 Btl Healthcare Technologies A.S. Method and device for pelvic floor tissue treatment
US11076879B2 (en) 2017-04-26 2021-08-03 Zeltiq Aesthetics, Inc. Shallow surface cryotherapy applicators and related technology
JP2021532873A (en) 2018-07-31 2021-12-02 ゼルティック エステティックス インコーポレイテッド Methods, devices, and systems to improve skin properties

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4798215A (en) * 1984-03-15 1989-01-17 Bsd Medical Corporation Hyperthermia apparatus
US6334074B1 (en) * 1997-07-31 2001-12-25 Microwave Medical Corp. Microwave applicator for therapeutic uses
US20050137662A1 (en) * 2001-02-28 2005-06-23 Rita Medical Systems, Inc. Tissue surface treatment apparatus and method

Family Cites Families (457)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2407690A (en) 1941-05-16 1946-09-17 Bell Telephone Labor Inc Wave guide electrotherapeutic system
US3307553A (en) 1963-01-30 1967-03-07 Edwin J Liebner Apparatus for cooling irradiated skin areas
US3527227A (en) 1965-09-17 1970-09-08 Karl Fritz Microwave electrodes for medical therapy
US3693623A (en) 1970-12-25 1972-09-26 Gregory System Inc Photocoagulation means and method for depilation
US3845267A (en) 1974-01-04 1974-10-29 Gen Electric Microwave oven with waveguide feed
US4069827A (en) 1975-08-20 1978-01-24 The Burdick Corporation Diathermy apparatus
US4174713A (en) 1976-03-26 1979-11-20 Mehl Thomas L Device for permanent removal of hair
US4095602A (en) 1976-09-27 1978-06-20 Leveen Harry H Multi-portal radiofrequency generator
US4108147A (en) 1976-11-01 1978-08-22 The United States Of America As Represented By The Department Of Health, Education And Welfare Direct contact microwave diathermy applicator
US4140130A (en) 1977-05-31 1979-02-20 Storm Iii Frederick K Electrode structure for radio frequency localized heating of tumor bearing tissue
US4190053A (en) 1977-06-20 1980-02-26 Rca Corporation Apparatus and method for hyperthermia treatment
US4228809A (en) 1977-10-06 1980-10-21 Rca Corporation Temperature controller for a microwave heating system
US4190056A (en) 1977-10-31 1980-02-26 General Medical Company Method and means for recording sweat gland activity
US4197860A (en) 1977-11-21 1980-04-15 Rca Corporation Hyperthermia applicator
US4315510A (en) 1979-05-16 1982-02-16 Cooper Medical Devices Corporation Method of performing male sterilization
US4672980A (en) 1980-04-02 1987-06-16 Bsd Medical Corporation System and method for creating hyperthermia in tissue
US4375220A (en) 1980-05-09 1983-03-01 Matvias Fredrick M Microwave applicator with cooling mechanism for intracavitary treatment of cancer
US4378806A (en) 1980-08-12 1983-04-05 Henley Cohn Julian L Gapped resonant microwave apparatus for producing hyperthermia therapy of tumors
US4388924A (en) 1981-05-21 1983-06-21 Weissman Howard R Method for laser depilation
FR2508801A1 (en) 1981-07-01 1983-01-07 Centre Nat Rech Scient MICROWAVE APPLICATOR FOR THE CREATION OF LOCALIZED HYPERTHERMIES
US4397313A (en) 1981-08-03 1983-08-09 Clini-Therm Corporation Multiple microwave applicator system and method for microwave hyperthermia treatment
US4397314A (en) 1981-08-03 1983-08-09 Clini-Therm Corporation Method and apparatus for controlling and optimizing the heating pattern for a hyperthermia system
US4446874A (en) 1981-12-30 1984-05-08 Clini-Therm Corporation Microwave applicator with discoupled input coupling and frequency tuning functions
GB2123287B (en) 1982-07-09 1986-03-05 Anna Gunilla Sutton Depilaton device
US5421819A (en) 1992-08-12 1995-06-06 Vidamed, Inc. Medical probe device
US5385544A (en) 1992-08-12 1995-01-31 Vidamed, Inc. BPH ablation method and apparatus
US4708716A (en) 1983-08-18 1987-11-24 Drug Delivery Systems Inc. Transdermal drug applicator
US4589424A (en) 1983-08-22 1986-05-20 Varian Associates, Inc Microwave hyperthermia applicator with variable radiation pattern
US4614191A (en) 1983-09-02 1986-09-30 Perler Robert F Skin-cooling probe
US4601296A (en) 1983-10-07 1986-07-22 Yeda Research And Development Co., Ltd. Hyperthermia apparatus
US5507741A (en) 1983-11-17 1996-04-16 L'esperance, Jr.; Francis A. Ophthalmic method for laser surgery of the cornea
US4690156A (en) 1984-03-04 1987-09-01 Tokyo Keiki Co., Ltd. Applicator for localized hyperthermia by electromagnetic waves
JPS61364A (en) 1984-04-28 1986-01-06 菊地 真 Applicator for heat treatment method
DK312884A (en) * 1984-06-27 1985-12-28 Joergen Bach Andersen APPLICATOR
JPS6131170A (en) 1984-07-24 1986-02-13 菊地 眞 Warming apparatus for hyperthermia
JPS6137259A (en) 1984-07-31 1986-02-22 菊地 真 Heating apparatus for hyperthermia
US4800899A (en) 1984-10-22 1989-01-31 Microthermia Technology, Inc. Apparatus for destroying cells in tumors and the like
US4632128A (en) * 1985-06-17 1986-12-30 Rca Corporation Antenna apparatus for scanning hyperthermia
US4669475A (en) 1985-06-28 1987-06-02 Bsd Medical Corporation Apparatus and method for hyperthermia treatment
US4891483A (en) 1985-06-29 1990-01-02 Tokyo Keiki Co. Ltd. Heating apparatus for hyperthermia
JPS622953A (en) 1985-06-29 1987-01-08 菊地 眞 Applicator for warming medical treatment
US4841990A (en) 1985-06-29 1989-06-27 Tokyo Keiki Co., Ltd. Applicator for use in hyperthermia
US4641649A (en) 1985-10-30 1987-02-10 Rca Corporation Method and apparatus for high frequency catheter ablation
US4700716A (en) 1986-02-27 1987-10-20 Kasevich Associates, Inc. Collinear antenna array applicator
JPS62149347U (en) 1986-03-13 1987-09-21
US5027829A (en) 1986-12-15 1991-07-02 Larsen Lawrence E Apparatus for diathermy treatment and control
JPS63177856A (en) 1987-01-16 1988-07-22 株式会社東芝 Hyperthermia apparatus
US4825880A (en) 1987-06-19 1989-05-02 The Regents Of The University Of California Implantable helical coil microwave antenna
US5073167A (en) 1987-06-26 1991-12-17 M/A-Com, Inc. In-line microwave warming apparatus
US5782897A (en) 1987-06-26 1998-07-21 Microwave Medical Systems, Inc. Microwave heating apparatus for rapid tissue fixation
US5919218A (en) 1987-06-26 1999-07-06 Microwave Medical Systems Cartridge for in-line microwave warming apparatus
US5143063A (en) 1988-02-09 1992-09-01 Fellner Donald G Method of removing adipose tissue from the body
US4860752A (en) 1988-02-18 1989-08-29 Bsd Medical Corporation Invasive microwave array with destructive and coherent phase
US4881543A (en) 1988-06-28 1989-11-21 Massachusetts Institute Of Technology Combined microwave heating and surface cooling of the cornea
US5344435A (en) 1988-07-28 1994-09-06 Bsd Medical Corporation Urethral inserted applicator prostate hyperthermia
FR2639238B1 (en) 1988-11-21 1991-02-22 Technomed Int Sa APPARATUS FOR SURGICAL TREATMENT OF TISSUES BY HYPERTHERMIA, PREFERABLY THE PROSTATE, COMPRISING MEANS OF THERMAL PROTECTION COMPRISING PREFERABLY RADIOREFLECTIVE SCREEN MEANS
FR2693116B1 (en) 1992-07-06 1995-04-28 Technomed Int Sa Urethral probe and apparatus for the therapeutic treatment of prostate tissue by thermotherapy.
US4945912A (en) 1988-11-25 1990-08-07 Sensor Electronics, Inc. Catheter with radiofrequency heating applicator
US4974587A (en) 1988-12-22 1990-12-04 Bsd Medical Corporation Applicator array and positioning system for hyperthermia
US5364394A (en) 1989-12-21 1994-11-15 Mehl Thomas L Method of removing hair from the body and inhibiting future growth
US5101836A (en) 1990-02-27 1992-04-07 The Board Of Trustees Of The Leland Stanford Junior University Flexible low profile microwave array for hyperthermia of superficially located tumors
US5059192A (en) 1990-04-24 1991-10-22 Nardo Zaias Method of hair depilation
US5186181A (en) 1990-07-27 1993-02-16 Cafiero Franconi Radio frequency thermotherapy
US5409484A (en) 1990-09-24 1995-04-25 Erlich; Frederick Cautery with smoke removal apparatus
JPH04150847A (en) 1990-10-12 1992-05-25 Katsuya Takasu Armpit smell surgical apparatus and chip for operation
US6223076B1 (en) 1990-11-01 2001-04-24 Robert Tapper Sweat control system
WO1992010932A1 (en) 1990-12-17 1992-07-09 Microwave Medical Systems, Inc. Therapeutic probe for radiating microwave and nuclear radiation
US5531662A (en) 1990-12-17 1996-07-02 Microwave Medical Systems, Inc. Dual mode microwave/ionizing probe
US5316000A (en) 1991-03-05 1994-05-31 Technomed International (Societe Anonyme) Use of at least one composite piezoelectric transducer in the manufacture of an ultrasonic therapy apparatus for applying therapy, in a body zone, in particular to concretions, to tissue, or to bones, of a living being and method of ultrasonic therapy
US5107832A (en) 1991-03-11 1992-04-28 Raul Guibert Universal thermotherapy applicator
JP3091253B2 (en) 1991-04-25 2000-09-25 オリンパス光学工業株式会社 Thermal treatment equipment
US5272301A (en) 1991-04-26 1993-12-21 Mmtc, Inc. Thermostatically-controlled microwave used for treatment of internal tissue of the eye
US5198776A (en) 1991-06-26 1993-03-30 Microwave Medical Systems, Inc. Microwave system for detecting gaseous emboli
US5441532A (en) 1991-06-26 1995-08-15 Massachusetts Institute Of Technology Adaptive focusing and nulling hyperthermia annular and monopole phased array applicators
US20010051803A1 (en) 1991-07-05 2001-12-13 Desai Jawahar M. Device and method for multi-phase radio-frequency ablation
US5383917A (en) 1991-07-05 1995-01-24 Jawahar M. Desai Device and method for multi-phase radio-frequency ablation
FR2680965B1 (en) 1991-09-05 1993-11-12 Gabriel Bernaz APPARATUS AND METHOD FOR TREATING SKIN.
US7549424B2 (en) 1991-10-18 2009-06-23 Pro Surg, Inc. Method and apparatus for tissue treatment with laser and electromagnetic radiation
US5817089A (en) 1991-10-29 1998-10-06 Thermolase Corporation Skin treatment process using laser
US5425728A (en) 1991-10-29 1995-06-20 Tankovich; Nicolai I. Hair removal device and method
US5226907A (en) 1991-10-29 1993-07-13 Tankovich Nikolai I Hair removal device and method
US5295955A (en) 1992-02-14 1994-03-22 Amt, Inc. Method and apparatus for microwave aided liposuction
ATE185956T1 (en) 1992-02-20 1999-11-15 Humanteknik Ab DEVICE FOR ATTACHING AN OBJECT TO A SURFACE USING VACUUM PRESSURE
US5306271A (en) 1992-03-09 1994-04-26 Izi Corporation Radiation therapy skin markers
US5540681A (en) 1992-04-10 1996-07-30 Medtronic Cardiorhythm Method and system for radiofrequency ablation of tissue
US5305748A (en) 1992-06-05 1994-04-26 Wilk Peter J Medical diagnostic system and related method
US20010050083A1 (en) 1992-10-28 2001-12-13 Marchitto Kevin S. Irradiation enhanced permeation and delivery
EP0597463A3 (en) 1992-11-13 1996-11-06 Dornier Med Systems Inc Thermotherapiesonde.
US5301692A (en) 1992-11-16 1994-04-12 Knowlton Edward W Method for total, immediate, post-mastectomy breast reconstruction using a latissimus dorsi myocutaneous flap
US5431650A (en) 1992-12-11 1995-07-11 Cosmescu; Ioan Vortex hand piece shroud for automatic smoke evacuator system for a surgical laser apparatus and method therefor
US5707403A (en) 1993-02-24 1998-01-13 Star Medical Technologies, Inc. Method for the laser treatment of subsurface blood vessels
US5443487A (en) 1993-03-05 1995-08-22 Guibert; Raul Combined chemo-thermo therapy technique
US5405346A (en) 1993-05-14 1995-04-11 Fidus Medical Technology Corporation Tunable microwave ablation catheter
US5464437A (en) 1993-07-08 1995-11-07 Urologix, Inc. Benign prostatic hyperplasia treatment catheter with urethral cooling
US5571154A (en) 1993-07-19 1996-11-05 Hunan University Microwave deep-diathermy apparatus
GB9315473D0 (en) 1993-07-27 1993-09-08 Chemring Ltd Treatment apparatus
SE503420C2 (en) 1993-11-16 1996-06-10 Humanteknik Ab Absorbent unit for use in a biomedical electrode
US6277111B1 (en) 1993-12-08 2001-08-21 Icn Photonics Limited Depilation
US5462521A (en) 1993-12-21 1995-10-31 Angeion Corporation Fluid cooled and perfused tip for a catheter
US5503150A (en) 1994-03-10 1996-04-02 Westinghouse Electric Corp. Apparatus and method for noninvasive microwave heating of tissue
US5989245A (en) 1994-03-21 1999-11-23 Prescott; Marvin A. Method and apparatus for therapeutic laser treatment
US5507790A (en) 1994-03-21 1996-04-16 Weiss; William V. Method of non-invasive reduction of human site-specific subcutaneous fat tissue deposits by accelerated lipolysis metabolism
US5584830A (en) 1994-03-30 1996-12-17 Medtronic Cardiorhythm Method and system for radiofrequency ablation of cardiac tissue
US5979454A (en) 1995-05-15 1999-11-09 The Regents Of The University Of California Method and apparatus for causing rapid and deep spatially selective coagulation during thermally mediated therapeutic procedures
JP3263275B2 (en) 1994-04-05 2002-03-04 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア Apparatus for laser treatment of living tissue and laser treatment apparatus for flame-like nevus
US6277116B1 (en) 1994-05-06 2001-08-21 Vidaderm Systems and methods for shrinking collagen in the dermis
US5586981A (en) 1994-08-25 1996-12-24 Xin-Hua Hu Treatment of cutaneous vascular and pigmented lesions
US5549639A (en) 1994-09-16 1996-08-27 Sandia Corporation Non-invasive hyperthermia apparatus including coaxial applicator having a non-invasive radiometric receiving antenna incorporated therein and method of use thereof
US5669916A (en) 1994-09-28 1997-09-23 The General Hospital Corporation Method of hair removal
US5674219A (en) 1994-10-06 1997-10-07 Donaldson Company, Inc. Electrosurgical smoke evacuator
US5632739A (en) 1994-10-13 1997-05-27 The General Hospital Corporation Two-pulse, lateral tissue illuminator
US5575789A (en) 1994-10-27 1996-11-19 Valleylab Inc. Energizable surgical tool safety device and method
US5735844A (en) 1995-02-01 1998-04-07 The General Hospital Corporation Hair removal using optical pulses
US5595568A (en) 1995-02-01 1997-01-21 The General Hospital Corporation Permanent hair removal using optical pulses
US6409722B1 (en) 1998-07-07 2002-06-25 Medtronic, Inc. Apparatus and method for creating, maintaining, and controlling a virtual electrode used for the ablation of tissue
US5688050A (en) * 1995-04-03 1997-11-18 Mmtc, Inc. Temperature-measuring microwave radiometer apparatus
US5569237A (en) 1995-04-27 1996-10-29 Beckenstein; Michael S. Marking device for breast surgery
US6575969B1 (en) 1995-05-04 2003-06-10 Sherwood Services Ag Cool-tip radiofrequency thermosurgery electrode system for tumor ablation
US5660836A (en) 1995-05-05 1997-08-26 Knowlton; Edward W. Method and apparatus for controlled contraction of collagen tissue
US6241753B1 (en) 1995-05-05 2001-06-05 Thermage, Inc. Method for scar collagen formation and contraction
US5755753A (en) 1995-05-05 1998-05-26 Thermage, Inc. Method for controlled contraction of collagen tissue
US6470216B1 (en) 1995-05-05 2002-10-22 Thermage, Inc. Method for smoothing contour irregularities of skin surface
US5683382A (en) 1995-05-15 1997-11-04 Arrow International Investment Corp. Microwave antenna catheter
US5769879A (en) 1995-06-07 1998-06-23 Medical Contouring Corporation Microwave applicator and method of operation
US6456865B2 (en) 1995-06-08 2002-09-24 Ilan Zadik Samson Non-invasive medical probe
US5810804A (en) 1995-08-15 1998-09-22 Rita Medical Systems Multiple antenna ablation apparatus and method with cooling element
US6210367B1 (en) 1995-09-06 2001-04-03 Microwave Medical Systems, Inc. Intracorporeal microwave warming method and apparatus
US5690614A (en) 1995-09-06 1997-11-25 Microwave Medical Systems, Inc. Microwave apparatus for warming low flow rate infusates
US5891094A (en) 1995-09-07 1999-04-06 Innerdyne, Inc. System for direct heating of fluid solution in a hollow body organ and methods
US5785708A (en) 1995-09-19 1998-07-28 Lp Systems Corporation Epilator probeholder
US5836999A (en) 1995-09-28 1998-11-17 Esc Medical Systems Ltd. Method and apparatus for treating psoriasis using pulsed electromagnetic radiation
US5824023A (en) 1995-10-12 1998-10-20 The General Hospital Corporation Radiation-delivery device
US6228078B1 (en) 1995-11-22 2001-05-08 Arthrocare Corporation Methods for electrosurgical dermatological treatment
US7758537B1 (en) 1995-11-22 2010-07-20 Arthrocare Corporation Systems and methods for electrosurgical removal of the stratum corneum
US5897549A (en) 1995-11-29 1999-04-27 Lumedics, Ltd. Transformation of unwanted tissue by deep laser heating of water
US5879346A (en) 1995-12-18 1999-03-09 Esc Medical Systems, Ltd. Hair removal by selective photothermolysis with an alexandrite laser
IL118229A0 (en) 1996-05-12 1997-03-18 Laser Ind Ltd Apparatus and method for cutaneous treatment employing a laser
US7141049B2 (en) 1999-03-09 2006-11-28 Thermage, Inc. Handpiece for treatment of tissue
US7006874B2 (en) 1996-01-05 2006-02-28 Thermage, Inc. Treatment apparatus with electromagnetic energy delivery device and non-volatile memory
US20030212393A1 (en) 1996-01-05 2003-11-13 Knowlton Edward W. Handpiece with RF electrode and non-volatile memory
US6350276B1 (en) 1996-01-05 2002-02-26 Thermage, Inc. Tissue remodeling apparatus containing cooling fluid
US7473251B2 (en) 1996-01-05 2009-01-06 Thermage, Inc. Methods for creating tissue effect utilizing electromagnetic energy and a reverse thermal gradient
US7189230B2 (en) 1996-01-05 2007-03-13 Thermage, Inc. Method for treating skin and underlying tissue
US20040000316A1 (en) 1996-01-05 2004-01-01 Knowlton Edward W. Methods for creating tissue effect utilizing electromagnetic energy and a reverse thermal gradient
US7022121B2 (en) 1999-03-09 2006-04-04 Thermage, Inc. Handpiece for treatment of tissue
US7115123B2 (en) 1996-01-05 2006-10-03 Thermage, Inc. Handpiece with electrode and non-volatile memory
US7229436B2 (en) 1996-01-05 2007-06-12 Thermage, Inc. Method and kit for treatment of tissue
US7452358B2 (en) 1996-01-05 2008-11-18 Thermage, Inc. RF electrode assembly for handpiece
US7267675B2 (en) 1996-01-05 2007-09-11 Thermage, Inc. RF device with thermo-electric cooler
US6682501B1 (en) 1996-02-23 2004-01-27 Gyrus Ent, L.L.C. Submucosal tonsillectomy apparatus and method
JP3872123B2 (en) * 1996-03-08 2007-01-24 伊藤超短波株式会社 Microwave therapy device
US5733269A (en) 1996-03-15 1998-03-31 Fuisz Technologies Ltd. Method and kit for positioning transdermal delivery system
US5983124A (en) 1996-04-03 1999-11-09 Microwave Medical Systems, Inc. Microwave detection of tumors, particularly breast tumors
US5662110A (en) 1996-04-03 1997-09-02 Microwave Medical Systems, Inc. Microwave detection apparatus for locating cancerous tumors particularly breast tumors
US5742392A (en) 1996-04-16 1998-04-21 Seymour Light, Inc. Polarized material inspection apparatus
US5904709A (en) 1996-04-17 1999-05-18 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Microwave treatment for cardiac arrhythmias
US6096029A (en) 1997-02-24 2000-08-01 Laser Skin Toner, Inc. Laser method for subsurface cutaneous treatment
US6106514A (en) 1996-08-12 2000-08-22 O'donnell, Jr.; Francis E. Laser method for subsurface cutaneous treatment
GB9618051D0 (en) 1996-08-29 1996-10-09 Sls Wales Ltd Wrinkle removal
US6214034B1 (en) 1996-09-04 2001-04-10 Radiancy, Inc. Method of selective photothermolysis
US6306128B1 (en) 1996-10-09 2001-10-23 Laser Industries Ltd. Cooling apparatus for cutaneous treatment employing a laser and method for operating same
US6216704B1 (en) 1997-08-13 2001-04-17 Surx, Inc. Noninvasive devices, methods, and systems for shrinking of tissues
US6480746B1 (en) 1997-08-13 2002-11-12 Surx, Inc. Noninvasive devices, methods, and systems for shrinking of tissues
US6517532B1 (en) 1997-05-15 2003-02-11 Palomar Medical Technologies, Inc. Light energy delivery head
US6015404A (en) 1996-12-02 2000-01-18 Palomar Medical Technologies, Inc. Laser dermatology with feedback control
US7204832B2 (en) * 1996-12-02 2007-04-17 Pálomar Medical Technologies, Inc. Cooling system for a photo cosmetic device
US6653618B2 (en) 2000-04-28 2003-11-25 Palomar Medical Technologies, Inc. Contact detecting method and apparatus for an optical radiation handpiece
US20080294152A1 (en) * 1996-12-02 2008-11-27 Palomar Medical Technologies, Inc. Cooling System For A Photocosmetic Device
US8182473B2 (en) * 1999-01-08 2012-05-22 Palomar Medical Technologies Cooling system for a photocosmetic device
US6162211A (en) 1996-12-05 2000-12-19 Thermolase Corporation Skin enhancement using laser light
GB9626512D0 (en) 1996-12-20 1997-02-05 Gyrus Medical Ltd An improved electrosurgical generator and system
US5830208A (en) 1997-01-31 1998-11-03 Laserlite, Llc Peltier cooled apparatus and methods for dermatological treatment
US5810801A (en) 1997-02-05 1998-09-22 Candela Corporation Method and apparatus for treating wrinkles in skin using radiation
US5882329A (en) 1997-02-12 1999-03-16 Prolifix Medical, Inc. Apparatus and method for removing stenotic material from stents
US5743899A (en) 1997-03-04 1998-04-28 Izi Medical Products Method and apparatus for marking skin with ink
DE19710676C2 (en) 1997-03-16 1999-06-02 Aesculap Meditec Gmbh Arrangement for photoablation
US5814996A (en) 1997-04-08 1998-09-29 Bowden's Automated Products, Inc. Leakage detector having shielded contacts
JP4056091B2 (en) 1997-05-15 2008-03-05 パロマー・メディカル・テクノロジーズ・インコーポレーテッド Dermatological treatment method and apparatus
US6475211B2 (en) 1997-06-17 2002-11-05 Cool Laser Optics, Inc. Method and apparatus for temperature control of biologic tissue with simultaneous irradiation
US6413253B1 (en) 1997-08-16 2002-07-02 Cooltouch Corporation Subsurface heating of material
US6277104B1 (en) 1997-08-25 2001-08-21 Mcneil-Ppc, Inc. Air permeable, liquid impermeable barrier structures and products made therefrom
WO2000053261A1 (en) 1999-03-08 2000-09-14 Asah Medico A/S An apparatus for tissue treatment and having a monitor for display of tissue features
JP3777415B2 (en) 1997-09-01 2006-05-24 アークレイ株式会社 Measuring site positioning method and jig
US5928797A (en) 1997-09-08 1999-07-27 Deliquescence Holdings, Inc. Temporary tattoo device and method
US6139546A (en) 1997-10-06 2000-10-31 Somnus Medical Technologies, Inc. Linear power control with digital phase lock
EP1026999B1 (en) 1997-10-08 2006-06-07 The General Hospital Corporation Phototherapy systems
US6280441B1 (en) 1997-12-15 2001-08-28 Sherwood Services Ag Apparatus and method for RF lesioning
US6113559A (en) 1997-12-29 2000-09-05 Klopotek; Peter J. Method and apparatus for therapeutic treatment of skin with ultrasound
US6325769B1 (en) 1998-12-29 2001-12-04 Collapeutics, Llc Method and apparatus for therapeutic treatment of skin
IL122840A (en) 1997-12-31 2002-04-21 Radiancy Inc Apparatus and methods for removing hair
DE19800416C2 (en) 1998-01-08 2002-09-19 Storz Karl Gmbh & Co Kg Device for the treatment of body tissue, in particular soft tissue close to the surface, by means of ultrasound
DE69941252D1 (en) 1998-01-14 2009-09-24 Ams Res Corp RIBBED ELECTRODES
US6026816A (en) 1998-01-22 2000-02-22 Candela Corporation Method of treating sleep-disordered breathing syndromes
US6149644A (en) 1998-02-17 2000-11-21 Altralight, Inc. Method and apparatus for epidermal treatment with computer controlled moving focused infrared light
US6080146A (en) 1998-02-24 2000-06-27 Altshuler; Gregory Method and apparatus for hair removal
US6047215A (en) 1998-03-06 2000-04-04 Sonique Surgical Systems, Inc. Method and apparatus for electromagnetically assisted liposuction
WO1999046005A1 (en) 1998-03-12 1999-09-16 Palomar Medical Technologies, Inc. System for electromagnetic radiation of the skin
WO1999047085A1 (en) 1998-03-17 1999-09-23 Kochamba Gary S Method and apparatus for stabilizing tissue
AU3363999A (en) 1998-03-27 1999-10-18 General Hospital Corporation, The Method and apparatus for the selective targeting of lipid-rich tissues
US6306130B1 (en) 1998-04-07 2001-10-23 The General Hospital Corporation Apparatus and methods for removing blood vessels
US6024095A (en) 1998-04-10 2000-02-15 Proteus Therapeutics, Inc. Corneal heat and stretch method and apparatus
DE19817553A1 (en) 1998-04-15 1999-10-21 Biotronik Mess & Therapieg Ablation arrangement
GB9809536D0 (en) 1998-05-06 1998-07-01 Microsulis Plc Sensor positioning
US6030378A (en) 1998-05-26 2000-02-29 Stewart; Bob W. Method of hair removal by transcutaneous application of laser light
US6036632A (en) 1998-05-28 2000-03-14 Barzell-Whitmore Maroon Bells, Inc. Sterile disposable template grid system
US6763836B2 (en) 1998-06-02 2004-07-20 Arthrocare Corporation Methods for electrosurgical tendon vascularization
US6077294A (en) 1998-06-11 2000-06-20 Cynosure, Inc. Method for non-invasive wrinkle removal and skin treatment
US6322584B2 (en) 1998-07-31 2001-11-27 Surx, Inc. Temperature sensing devices and methods to shrink tissues
US6139569A (en) 1998-07-31 2000-10-31 Surx, Inc. Interspersed heating/cooling to shrink tissues for incontinence
US6485703B1 (en) 1998-07-31 2002-11-26 The Texas A&M University System Compositions and methods for analyte detection
GB9817078D0 (en) 1998-08-05 1998-10-07 Habib Nagy A Device for liver surgery
US6443914B1 (en) 1998-08-10 2002-09-03 Lysonix, Inc. Apparatus and method for preventing and treating cellulite
US6245062B1 (en) 1998-10-23 2001-06-12 Afx, Inc. Directional reflector shield assembly for a microwave ablation instrument
TW558982U (en) 1998-10-26 2003-10-21 Matsushita Electric Works Ltd Facial aesthetic treatment apparatus
US6451015B1 (en) 1998-11-18 2002-09-17 Sherwood Services Ag Method and system for menu-driven two-dimensional display lesion generator
EP1131038A1 (en) 1998-11-20 2001-09-12 The General Hospital Corporation Permanent, removable tissue markings
US6887260B1 (en) 1998-11-30 2005-05-03 Light Bioscience, Llc Method and apparatus for acne treatment
US6283956B1 (en) 1998-11-30 2001-09-04 David H. McDaniels Reduction, elimination, or stimulation of hair growth
US6663659B2 (en) 2000-01-13 2003-12-16 Mcdaniel David H. Method and apparatus for the photomodulation of living cells
US6936044B2 (en) 1998-11-30 2005-08-30 Light Bioscience, Llc Method and apparatus for the stimulation of hair growth
US6676655B2 (en) 1998-11-30 2004-01-13 Light Bioscience L.L.C. Low intensity light therapy for the manipulation of fibroblast, and fibroblast-derived mammalian cells and collagen
US6514242B1 (en) 1998-12-03 2003-02-04 David Vasily Method and apparatus for laser removal of hair
US6330479B1 (en) 1998-12-07 2001-12-11 The Regents Of The University Of California Microwave garment for heating and/or monitoring tissue
US6402739B1 (en) 1998-12-08 2002-06-11 Y-Beam Technologies, Inc. Energy application with cooling
US6428532B1 (en) 1998-12-30 2002-08-06 The General Hospital Corporation Selective tissue targeting by difference frequency of two wavelengths
US6183773B1 (en) 1999-01-04 2001-02-06 The General Hospital Corporation Targeting of sebaceous follicles as a treatment of sebaceous gland disorders
US6113593A (en) 1999-02-01 2000-09-05 Tu; Lily Chen Ablation apparatus having temperature and force sensing capabilities
US6097985A (en) 1999-02-09 2000-08-01 Kai Technologies, Inc. Microwave systems for medical hyperthermia, thermotherapy and diagnosis
US6181970B1 (en) 1999-02-09 2001-01-30 Kai Technologies, Inc. Microwave devices for medical hyperthermia, thermotherapy and diagnosis
US6427089B1 (en) 1999-02-19 2002-07-30 Edward W. Knowlton Stomach treatment apparatus and method
GB9904373D0 (en) 1999-02-25 1999-04-21 Microsulis Plc Radiation applicator
GB9905173D0 (en) 1999-03-05 1999-04-28 Sls Biophile Limited Wrinkle reduction
US20020156471A1 (en) 1999-03-09 2002-10-24 Stern Roger A. Method for treatment of tissue
ES2240078T3 (en) 1999-03-09 2005-10-16 Thermage, Inc. APPARATUS FOR TREATMENT OF FABRICS.
US6569155B1 (en) 1999-03-15 2003-05-27 Altus Medical, Inc. Radiation delivery module and dermal tissue treatment method
US6383176B1 (en) 1999-03-15 2002-05-07 Altus Medical, Inc. Hair removal device and method
US6235016B1 (en) 1999-03-16 2001-05-22 Bob W. Stewart Method of reducing sebum production by application of pulsed light
US7107997B1 (en) 1999-03-16 2006-09-19 Jeffrey Warren Moses Method and apparatus for increasing angiogenic, growth factor in heart muscle
US6161049A (en) 1999-03-26 2000-12-12 Urologix, Inc. Thermal therapy catheter
US6702811B2 (en) 1999-04-05 2004-03-09 Medtronic, Inc. Ablation catheter assembly with radially decreasing helix and method of use
US6162212A (en) 1999-04-19 2000-12-19 Esc Medical Systems, Ltd. Optimal procedure for performing a hair removal
US6939346B2 (en) 1999-04-21 2005-09-06 Oratec Interventions, Inc. Method and apparatus for controlling a temperature-controlled probe
US6287302B1 (en) 1999-06-14 2001-09-11 Fidus Medical Technology Corporation End-firing microwave ablation instrument with horn reflection device
AU2002359840A1 (en) 1999-06-30 2003-07-09 Thermage, Inc. Liquid cooled RF handpiece
US6290699B1 (en) 1999-07-07 2001-09-18 Uab Research Foundation Ablation tool for forming lesions in body tissue
US6451007B1 (en) 1999-07-29 2002-09-17 Dale E. Koop Thermal quenching of tissue
US20020087155A1 (en) 1999-08-30 2002-07-04 Underwood Ronald A. Systems and methods for intradermal collagen stimulation
FR2798296B1 (en) 1999-09-13 2002-05-31 Centre Nat Rech Scient ASSEMBLY FOR HEAT TREATMENT OF BIOLOGICAL TISSUES AND METHOD FOR IMPLEMENTING SAME
US6607520B2 (en) 1999-09-15 2003-08-19 The General Hospital Corporation Coiled ablation catheter system
DE19949426C2 (en) 1999-10-13 2003-03-13 Wolf Gmbh Richard Acoustic therapy device
US6410496B1 (en) 1999-10-29 2002-06-25 The Procter & Gamble Company Laundry devices for delivering dye transfer inhibiting benefits
US7066929B1 (en) 1999-12-02 2006-06-27 Radiancy Inc. Selective photothermolysis
US6743222B2 (en) 1999-12-10 2004-06-01 Candela Corporation Method of treating disorders associated with sebaceous follicles
IL133592A0 (en) 1999-12-19 2001-04-30 Impulse Dynamics Ltd Fluid phase electrode lead
US6347251B1 (en) 1999-12-23 2002-02-12 Tianquan Deng Apparatus and method for microwave hyperthermia and acupuncture
US6387103B2 (en) 1999-12-30 2002-05-14 Aq Technologies, Inc. Instruments and techniques for inducing neocollagenesis in skin treatments
US7033352B1 (en) 2000-01-18 2006-04-25 Afx, Inc. Flexible ablation instrument
US6409720B1 (en) 2000-01-19 2002-06-25 Medtronic Xomed, Inc. Methods of tongue reduction using high intensity focused ultrasound to form an ablated tissue area containing a plurality of lesions
US6595934B1 (en) 2000-01-19 2003-07-22 Medtronic Xomed, Inc. Methods of skin rejuvenation using high intensity focused ultrasound to form an ablated tissue area containing a plurality of lesions
US6451013B1 (en) 2000-01-19 2002-09-17 Medtronic Xomed, Inc. Methods of tonsil reduction using high intensity focused ultrasound to form an ablated tissue area containing a plurality of lesions
US6413254B1 (en) 2000-01-19 2002-07-02 Medtronic Xomed, Inc. Method of tongue reduction by thermal ablation using high intensity focused ultrasound
US6692450B1 (en) 2000-01-19 2004-02-17 Medtronic Xomed, Inc. Focused ultrasound ablation devices having selectively actuatable ultrasound emitting elements and methods of using the same
US6361531B1 (en) 2000-01-21 2002-03-26 Medtronic Xomed, Inc. Focused ultrasound ablation devices having malleable handle shafts and methods of using the same
US6853864B2 (en) 2000-02-02 2005-02-08 Catholic University Of America, The Use of electromagnetic fields in cancer and other therapies
US6558314B1 (en) * 2000-02-11 2003-05-06 Iotek, Inc. Devices and method for manipulation of organ tissue
US7565205B2 (en) 2000-02-17 2009-07-21 Standen Ltd. Treating a tumor or the like with electric fields at different orientations
US7136699B2 (en) 2002-10-02 2006-11-14 Standen, Ltd. Apparatus for destroying dividing cells
US7089054B2 (en) 2002-10-02 2006-08-08 Standen Ltd. Apparatus and method for treating a tumor or the like
US7862564B2 (en) 2000-02-22 2011-01-04 Plasmogen Inc. Method of remodelling stretch marks
US6629974B2 (en) 2000-02-22 2003-10-07 Gyrus Medical Limited Tissue treatment method
US6436094B1 (en) 2000-03-16 2002-08-20 Laserscope, Inc. Electromagnetic and laser treatment and cooling device
US6471696B1 (en) 2000-04-12 2002-10-29 Afx, Inc. Microwave ablation instrument with a directional radiation pattern
US6725095B2 (en) 2000-04-13 2004-04-20 Celsion Corporation Thermotherapy method for treatment and prevention of cancer in male and female patients and cosmetic ablation of tissue
US6514250B1 (en) 2000-04-27 2003-02-04 Medtronic, Inc. Suction stabilized epicardial ablation devices
WO2001082811A1 (en) 2000-04-27 2001-11-08 Medtronic, Inc. System and method for assessing transmurality of ablation lesions
US6558382B2 (en) 2000-04-27 2003-05-06 Medtronic, Inc. Suction stabilized epicardial ablation devices
DE60141758D1 (en) 2000-08-16 2010-05-20 Gen Hospital Corp Topische aminolevulinsäure-photodynamische therapie für akne vulgaris
US20040073115A1 (en) 2000-08-24 2004-04-15 Timi 3 Systems, Inc. Systems and methods for applying ultrasound energy to increase tissue perfusion and/or vasodilation without substantial deep heating of tissue
AU2002220041C1 (en) 2000-11-03 2008-09-18 Eleme Medical Inc. System and method for tissue treatment
US6475179B1 (en) 2000-11-10 2002-11-05 New England Medical Center Tissue folding device for tissue ablation, and method thereof
US6821274B2 (en) 2001-03-07 2004-11-23 Gendel Ltd. Ultrasound therapy for selective cell ablation
US6808532B2 (en) 2000-12-15 2004-10-26 Dan E. Andersen Laser treatment for reducing wrinkles
US6626854B2 (en) 2000-12-27 2003-09-30 Insightec - Txsonics Ltd. Systems and methods for ultrasound assisted lipolysis
US6645162B2 (en) 2000-12-27 2003-11-11 Insightec - Txsonics Ltd. Systems and methods for ultrasound assisted lipolysis
CA2433022C (en) 2000-12-28 2016-12-06 Palomar Medical Technologies, Inc. Method and apparatus for therapeutic emr treatment of the skin
US20060004347A1 (en) 2000-12-28 2006-01-05 Palomar Medical Technologies, Inc. Methods and products for producing lattices of EMR-treated islets in tissues, and uses therefor
US20020087151A1 (en) 2000-12-29 2002-07-04 Afx, Inc. Tissue ablation apparatus with a sliding ablation instrument and method
US6607498B2 (en) 2001-01-03 2003-08-19 Uitra Shape, Inc. Method and apparatus for non-invasive body contouring by lysing adipose tissue
US7347855B2 (en) 2001-10-29 2008-03-25 Ultrashape Ltd. Non-invasive ultrasonic body contouring
EP1362223B1 (en) 2001-01-03 2008-05-21 Ultrashape Inc. Non-invasive ultrasonic body contouring
US6837848B2 (en) 2003-01-15 2005-01-04 Medtronic, Inc. Methods and apparatus for accessing and stabilizing an area of the heart
JP2002214306A (en) 2001-01-15 2002-07-31 Hitachi Ltd Semiconductor integrated circuit
US6457476B1 (en) * 2001-01-23 2002-10-01 The Procter & Gamble Company Applicator for applying liquid products to hair
US6888319B2 (en) 2001-03-01 2005-05-03 Palomar Medical Technologies, Inc. Flashlamp drive circuit
CN1251649C (en) 2001-03-30 2006-04-19 皇家菲利浦电子有限公司 Skin treating device comprising protected radiation exit opening
US6861954B2 (en) 2001-03-30 2005-03-01 Bruce H. Levin Tracking medical products with integrated circuits
US20020165529A1 (en) 2001-04-05 2002-11-07 Danek Christopher James Method and apparatus for non-invasive energy delivery
EP1385438A2 (en) 2001-04-20 2004-02-04 Koninklijke Philips Electronics N.V. Skin treating device with protection against radiation pulse overdose
GB0111986D0 (en) 2001-05-16 2001-07-04 Optomed As Cryosurgical apparatus and methods
US20020193851A1 (en) 2001-06-14 2002-12-19 Silverman David E. Energy treatment apparatus for treating gastrointestinal tract and method for using same
BR0117084A (en) 2001-06-27 2004-08-03 Radiancy Inc Apparatus for improving acne symptoms of a skin region
US6723090B2 (en) 2001-07-02 2004-04-20 Palomar Medical Technologies, Inc. Fiber laser device for medical/cosmetic procedures
US20060167498A1 (en) 2001-07-23 2006-07-27 Dilorenzo Daniel J Method, apparatus, and surgical technique for autonomic neuromodulation for the treatment of disease
US6939344B2 (en) 2001-08-02 2005-09-06 Syneron Medical Ltd. Method for controlling skin temperature during thermal treatment
US7734355B2 (en) 2001-08-31 2010-06-08 Bio Control Medical (B.C.M.) Ltd. Treatment of disorders by unidirectional nerve stimulation
US6652518B2 (en) 2001-09-28 2003-11-25 Ethicon, Inc. Transmural ablation tool and method
DE60210111T2 (en) 2001-09-28 2007-03-29 Rita Medical Systems, Inc., Mountain View IMPEDANCE-CONTROLLED DEVICE FOR THE ABLATION OF TISSUE
US6585733B2 (en) 2001-09-28 2003-07-01 Ethicon, Inc. Surgical treatment for atrial fibrillation using radiofrequency technology
US6878147B2 (en) 2001-11-02 2005-04-12 Vivant Medical, Inc. High-strength microwave antenna assemblies
US7128739B2 (en) * 2001-11-02 2006-10-31 Vivant Medical, Inc. High-strength microwave antenna assemblies and methods of use
US6916328B2 (en) 2001-11-15 2005-07-12 Expanding Concepts, L.L.C Percutaneous cellulite removal system
US7329274B2 (en) 2001-11-29 2008-02-12 Palomar Medical Technologies, Inc. Conforming oral phototherapy applicator
US6648904B2 (en) 2001-11-29 2003-11-18 Palomar Medical Technologies, Inc. Method and apparatus for controlling the temperature of a surface
US7591818B2 (en) 2001-12-04 2009-09-22 Endoscopic Technologies, Inc. Cardiac ablation devices and methods
EP1627662B1 (en) 2004-06-10 2011-03-02 Candela Corporation Apparatus for vacuum-assisted light-based treatments of the skin
US7762965B2 (en) 2001-12-10 2010-07-27 Candela Corporation Method and apparatus for vacuum-assisted light-based treatments of the skin
US7762964B2 (en) 2001-12-10 2010-07-27 Candela Corporation Method and apparatus for improving safety during exposure to a monochromatic light source
WO2003057059A1 (en) 2001-12-27 2003-07-17 Palomar Medical Technologies, Inc. Method and apparatus for improved vascular related treatment
US7153285B2 (en) 2002-01-17 2006-12-26 Baxter International Inc. Medical fluid heater using radiant energy
US6907879B2 (en) 2002-02-04 2005-06-21 Ndt Agent delivery and aspiration device
EP1474057B1 (en) 2002-02-12 2007-03-28 Oratec Interventions, Inc Radiofrequency arthroscopic ablation device
US7258674B2 (en) 2002-02-20 2007-08-21 Liposonix, Inc. Ultrasonic treatment and imaging of adipose tissue
US7163536B2 (en) 2004-06-10 2007-01-16 Baylis Medical Company Inc. Determining connections of multiple energy sources and energy delivery devices
IL163946A0 (en) 2002-03-12 2005-12-18 Gen Hospital Corp Method and apparatus for hair growth managment
US8840608B2 (en) 2002-03-15 2014-09-23 The General Hospital Corporation Methods and devices for selective disruption of fatty tissue by controlled cooling
CN110522505B (en) 2002-03-15 2023-04-25 总医院公司 System for selective destruction of adipose tissue by controlled cooling
US20030181890A1 (en) * 2002-03-22 2003-09-25 Schulze Dale R. Medical device that removably attaches to a bodily organ
US6662054B2 (en) 2002-03-26 2003-12-09 Syneron Medical Ltd. Method and system for treating skin
US7056318B2 (en) 2002-04-12 2006-06-06 Reliant Technologies, Inc. Temperature controlled heating device and method to heat a selected area of a biological body
US6887239B2 (en) 2002-04-17 2005-05-03 Sontra Medical Inc. Preparation for transmission and reception of electrical signals
US20070239142A1 (en) 2006-03-10 2007-10-11 Palomar Medical Technologies, Inc. Photocosmetic device
BR0312430A (en) 2002-06-19 2005-04-26 Palomar Medical Tech Inc Method and apparatus for treating skin and subcutaneous conditions
BR0311901A (en) 2002-06-19 2005-04-05 Gen Hospital Corp Process and apparatus for photothermal deep tissue treatment
US20030234194A1 (en) 2002-06-21 2003-12-25 Clark Dan Warren Protective shield for a patient control unit
CN1662177A (en) 2002-06-25 2005-08-31 超形态公司 Appts. and method for shape aesthetics
US7442192B2 (en) * 2002-07-14 2008-10-28 Knowlton Edward W Method and apparatus for surgical dissection
US7740600B2 (en) 2002-08-02 2010-06-22 Candela Corporation Apparatus and method for inhibiting pain signals transmitted during a skin related medical treatment
US7250047B2 (en) 2002-08-16 2007-07-31 Lumenis Ltd. System and method for treating tissue
US6807446B2 (en) 2002-09-03 2004-10-19 Celsion Corporation Monopole phased array thermotherapy applicator for deep tumor therapy
GB2387544B (en) 2002-10-10 2004-03-17 Microsulis Plc Microwave applicator
EP2522293A2 (en) 2002-10-23 2012-11-14 Palomar Medical Technologies, Inc. Phototreatment device for use with coolants and topical substances
US6896666B2 (en) 2002-11-08 2005-05-24 Kochamba Family Trust Cutaneous injection delivery under suction
US6824542B2 (en) 2002-11-08 2004-11-30 Harvey H. Jay Temporary hair removal method
US6916316B2 (en) 2002-11-08 2005-07-12 Harvey H. Jay Hair treatment method
US20060264926A1 (en) 2002-11-08 2006-11-23 Kochamba Gary S Cutaneous stabilization by vacuum for delivery of micro-needle array
US7377917B2 (en) 2002-12-09 2008-05-27 The Trustees Of Dartmouth College Feedback control of thermokeratoplasty treatments
EP1575436A1 (en) 2002-12-18 2005-09-21 Koninklijke Philips Electronics N.V. A device for treating human skin by means of radiation
US7153256B2 (en) 2003-03-07 2006-12-26 Neuronetics, Inc. Reducing discomfort caused by electrical stimulation
US9149322B2 (en) 2003-03-31 2015-10-06 Edward Wells Knowlton Method for treatment of tissue
US20040206365A1 (en) 2003-03-31 2004-10-21 Knowlton Edward Wells Method for treatment of tissue
ITBO20030186A1 (en) 2003-04-01 2004-10-02 Gen Project Srl EQUIPMENT FOR SKIN MASSAGE.
US7220778B2 (en) 2003-04-15 2007-05-22 The General Hospital Corporation Methods and devices for epithelial protection during photodynamic therapy
US7238182B2 (en) 2003-04-25 2007-07-03 Medtronic, Inc. Device and method for transurethral prostate treatment
CA2525892A1 (en) 2003-05-16 2004-12-02 Waverx, Inc. Apparatus and method for the treatment of infectious disease in keratinized tissue
US6974415B2 (en) 2003-05-22 2005-12-13 Magnetus Llc Electromagnetic-acoustic imaging
US6957108B2 (en) 2003-06-02 2005-10-18 Bsd Medical Corporation Invasive microwave antenna array for hyperthermia and brachytherapy
US7074218B2 (en) 2003-06-30 2006-07-11 Ethicon, Inc. Multi-modality ablation device
US20050010271A1 (en) 2003-07-07 2005-01-13 Merchant Robert F. Method of using radiation to treat cutaneous and sub-cutaneous conditions
US7725176B2 (en) 2003-07-10 2010-05-25 Schuler Eleanor L Method and system for regulation of endocrine and exocrine glands by means of neuro-electrical coded signals
US7291140B2 (en) 2003-07-18 2007-11-06 Cutera, Inc. System and method for low average power dermatologic light treatment device
US7344587B2 (en) 2003-08-06 2008-03-18 The General Hospital Corporation Magnetic ink tissue markings
US7722600B2 (en) 2003-08-25 2010-05-25 Cutera, Inc. System and method for heating skin using light to provide tissue treatment
US7544204B2 (en) 2003-10-15 2009-06-09 Valam Corporation Control of halitosis-generating and other microorganisms in the non-dental upper respiratory tract
DE10354025B4 (en) * 2003-11-19 2022-03-24 Carl Zeiss Meditec Ag Adapter for mechanically coupling a laser processing device to an object
US7613523B2 (en) 2003-12-11 2009-11-03 Apsara Medical Corporation Aesthetic thermal sculpting of skin
US7857773B2 (en) 2003-12-30 2010-12-28 Medicis Technologies Corporation Apparatus and methods for the destruction of adipose tissue
US20050154308A1 (en) 2003-12-30 2005-07-14 Liposonix, Inc. Disposable transducer seal
WO2005065565A1 (en) 2003-12-31 2005-07-21 Palomar Medical Technologies, Inc. Dermatological treatment with vusualization
US20050154332A1 (en) 2004-01-12 2005-07-14 Onda Methods and systems for removing hair using focused acoustic energy
JP3952021B2 (en) 2004-01-19 2007-08-01 松下電工株式会社 Facial massager
JP3991990B2 (en) 2004-01-19 2007-10-17 松下電工株式会社 Facial massager
ES2629960T3 (en) 2004-03-25 2017-08-16 University College Cork-National University Of Ireland, Cork Apparatus for prophylaxis or tissue treatment
JP5065005B2 (en) 2004-04-01 2012-10-31 ザ ジェネラル ホスピタル コーポレイション Method and apparatus for dermatological treatment and tissue remodeling
US20070055224A1 (en) 2004-04-29 2007-03-08 Lee Fred T Jr Intralumenal microwave device
US20070179482A1 (en) * 2004-05-07 2007-08-02 Anderson Robert S Apparatuses and methods to treat biological external tissue
US7842029B2 (en) 2004-05-07 2010-11-30 Aesthera Apparatus and method having a cooling material and reduced pressure to treat biological external tissue
US20050251117A1 (en) 2004-05-07 2005-11-10 Anderson Robert S Apparatus and method for treating biological external tissue
US8571648B2 (en) 2004-05-07 2013-10-29 Aesthera Apparatus and method to apply substances to tissue
JP2007536987A (en) 2004-05-13 2007-12-20 ウェイブレクス,インコーポレイテッド Apparatus and method for treating infectious disease of keratinized tissue
US7241291B2 (en) 2004-06-02 2007-07-10 Syneron Medical Ltd. Method and system for skin treatment using light energy and skin deformation
EP1758518A2 (en) 2004-06-07 2007-03-07 Edwards Lifesciences Corporation Methods and devices for directionally ablating tissue
US7311674B2 (en) 2004-06-28 2007-12-25 Scimed Life Systems, Inc. End effector assembly cap and tissue removal device and related methods
US20060036300A1 (en) 2004-08-16 2006-02-16 Syneron Medical Ltd. Method for lypolisis
US7530958B2 (en) 2004-09-24 2009-05-12 Guided Therapy Systems, Inc. Method and system for combined ultrasound treatment
US7758524B2 (en) 2004-10-06 2010-07-20 Guided Therapy Systems, L.L.C. Method and system for ultra-high frequency ultrasound treatment
KR101605527B1 (en) 2004-10-06 2016-03-22 가이디드 테라피 시스템스, 엘.엘.씨. Ultrasound treatment system
US20060111744A1 (en) 2004-10-13 2006-05-25 Guided Therapy Systems, L.L.C. Method and system for treatment of sweat glands
US7530356B2 (en) 2004-10-06 2009-05-12 Guided Therapy Systems, Inc. Method and system for noninvasive mastopexy
US20060112698A1 (en) 2004-12-01 2006-06-01 Gaymar Industries, Inc. Medical configuration of vortex tubes and method of use
EP1824539A1 (en) 2004-12-08 2007-08-29 Novo Nordisk A/S Apparatus and method for assisting in choosing a site for a skin invasive action
US7749260B2 (en) 2004-12-10 2010-07-06 Da Silva Luiz B Devices and methods for treatment of skin conditions
US7568619B2 (en) 2004-12-15 2009-08-04 Alcon, Inc. System and method for identifying and controlling ophthalmic surgical devices and components
ES2383376T3 (en) 2005-01-18 2012-06-20 Alma Lasers Ltd Improved system to heat biological tissue using RF energy
US7643883B2 (en) 2005-01-28 2010-01-05 Syneron Medical Ltd. Device and method for treating skin
US7234739B2 (en) 2005-02-10 2007-06-26 Washin Optical Co., Ltd. Magnetic latch assembly
BRPI0607903A2 (en) 2005-02-18 2009-10-20 Palomar Medical Tech Inc dermatological treatment device
US7390089B2 (en) 2005-02-25 2008-06-24 20/10 Perfect Vision Optische Geraete Gmbh Device and method for aligning an eye with a surgical laser
US7722656B1 (en) 2005-02-25 2010-05-25 Kim Robin Segal Device and method for stimulating hair growth
US8157807B2 (en) 2005-06-02 2012-04-17 The Invention Science Fund I, Llc Skin treatment including patterned light
US7857775B2 (en) 2005-03-15 2010-12-28 Syneron Medical Ltd. Method for soft tissue treatment
WO2006106436A2 (en) 2005-04-05 2006-10-12 Renewave Medical Systems Sa System and method using microwaves to improve ultrasound imaging
US20060265034A1 (en) 2005-04-05 2006-11-23 Ams Medical Sa Microwave devices for treating biological samples and tissue and methods for using same
JP2006289098A (en) 2005-04-12 2006-10-26 Inolase 2002 Ltd Apparatus for vacuum-assisted light-based treatment of skin
US7479101B2 (en) 2005-04-21 2009-01-20 Ksm, Inc. Method for treating an animal using a constant amplitude electromagnetic field
US7837694B2 (en) 2005-04-28 2010-11-23 Warsaw Orthopedic, Inc. Method and apparatus for surgical instrument identification
US7799019B2 (en) 2005-05-10 2010-09-21 Vivant Medical, Inc. Reinforced high strength microwave antenna
US7217265B2 (en) 2005-05-18 2007-05-15 Cooltouch Incorporated Treatment of cellulite with mid-infrared radiation
US7651708B2 (en) 2005-07-22 2010-01-26 Mars, Inc. Method of producing an animal food product with a core and shell
US7290326B2 (en) 2005-07-22 2007-11-06 Dynaco Corp. Method and apparatus for forming multi-layered circuits using liquid crystalline polymers
CA2621535A1 (en) 2005-09-07 2007-03-15 The Foundry, Inc. Apparatus and method for disrupting subcutaneous structures
US9486274B2 (en) 2005-09-07 2016-11-08 Ulthera, Inc. Dissection handpiece and method for reducing the appearance of cellulite
US7967763B2 (en) 2005-09-07 2011-06-28 Cabochon Aesthetics, Inc. Method for treating subcutaneous tissues
WO2007038567A1 (en) 2005-09-28 2007-04-05 Candela Corporation Treating cellulite
US20070078290A1 (en) 2005-09-30 2007-04-05 Esenaliev Rinat O Ultrasound-based treatment methods for therapeutic treatment of skin and subcutaneous tissues
US20070078502A1 (en) 2005-10-05 2007-04-05 Thermage, Inc. Method and apparatus for estimating a local impedance factor
US8702691B2 (en) * 2005-10-19 2014-04-22 Thermage, Inc. Treatment apparatus and methods for delivering energy at multiple selectable depths in tissue
US7611507B2 (en) 2005-10-24 2009-11-03 Amo Development Llc Disposable patient interface
US7565207B2 (en) 2005-11-22 2009-07-21 Bsd Medical Corporation Apparatus for creating hyperthermia in tissue
US7891362B2 (en) 2005-12-23 2011-02-22 Candela Corporation Methods for treating pigmentary and vascular abnormalities in a dermal region
US7763060B2 (en) 2006-02-22 2010-07-27 Baumann Nicholas R Patient warming drape
US7854754B2 (en) 2006-02-22 2010-12-21 Zeltiq Aesthetics, Inc. Cooling device for removing heat from subcutaneous lipid-rich cells
US7828734B2 (en) 2006-03-09 2010-11-09 Slender Medical Ltd. Device for ultrasound monitored tissue treatment
US7736360B2 (en) 2006-03-17 2010-06-15 Microcube, Llc Devices and methods for creating continuous lesions
JP5027110B2 (en) * 2006-03-22 2012-09-19 パナソニック株式会社 Laser drilling device
US7864129B2 (en) 2006-04-04 2011-01-04 Namiki Seimitsu Houseki Kabushiki Kaisha Radio frequency medical treatment device and system and usage method thereof
WO2007117580A2 (en) 2006-04-06 2007-10-18 Palomar Medical Technologies, Inc. Apparatus and method for skin treatment with compression and decompression
US20070255362A1 (en) 2006-04-28 2007-11-01 Juniper Medical, Inc. Cryoprotectant for use with a cooling device for improved cooling of subcutaneous lipid-rich cells
JP2009536083A (en) 2006-05-03 2009-10-08 インディアナ・ユニバーシティ・リサーチ・アンド・テクノロジー・コーポレーション Method and apparatus for reconstructing the esophagus and other body lumens
US7615036B2 (en) 2006-05-11 2009-11-10 Kalypto Medical, Inc. Device and method for wound therapy
US20070270925A1 (en) 2006-05-17 2007-11-22 Juniper Medical, Inc. Method and apparatus for non-invasively removing heat from subcutaneous lipid-rich cells including a coolant having a phase transition temperature
US8361621B2 (en) 2006-05-31 2013-01-29 Dow Global Technologies Llc Additives for the use of microwave energy to selectively heat thermoplastic polymer systems
US20080195000A1 (en) 2006-09-06 2008-08-14 Spooner Gregory J R System and Method for Dermatological Treatment Using Ultrasound
US9132031B2 (en) 2006-09-26 2015-09-15 Zeltiq Aesthetics, Inc. Cooling device having a plurality of controllable cooling elements to provide a predetermined cooling profile
US20080077201A1 (en) 2006-09-26 2008-03-27 Juniper Medical, Inc. Cooling devices with flexible sensors
US8192474B2 (en) 2006-09-26 2012-06-05 Zeltiq Aesthetics, Inc. Tissue treatment methods
US8142426B2 (en) 2006-10-16 2012-03-27 Syneron Medical Ltd. Methods and devices for treating tissue
US20100211059A1 (en) 2007-04-19 2010-08-19 Deem Mark E Systems and methods for creating an effect using microwave energy to specified tissue
US9149331B2 (en) 2007-04-19 2015-10-06 Miramar Labs, Inc. Methods and apparatus for reducing sweat production
CN101711134B (en) 2007-04-19 2016-08-17 米勒玛尔实验室公司 Tissue is applied the system of microwave energy and in organized layer, produces the system of tissue effect
JP2010524589A (en) 2007-04-19 2010-07-22 ザ ファウンドリー, インコーポレイテッド Method, apparatus and system for non-invasive delivery of microwave therapy
US8423152B2 (en) * 2007-05-14 2013-04-16 Bsd Medical Corporation Apparatus and method for selectively heating a deposit in fatty tissue in a body
US20090306646A1 (en) * 2007-05-14 2009-12-10 Bsd Medical Corporation Apparatus and method for injection enhancement of selective heating of a deposit in tissues in a body
US7740651B2 (en) 2007-09-28 2010-06-22 Candela Corporation Vacuum assisted treatment of the skin
JP2011505899A (en) 2007-12-05 2011-03-03 シネロン メディカル リミテッド Disposable electromagnetic energy applicator and method of using the same
AU2008335715B2 (en) 2007-12-12 2014-01-23 Miradry, Inc. Systems, apparatus, methods and procedures for the noninvasive treatment of tissue using microwave energy
ES2471971T3 (en) 2007-12-12 2014-06-27 Miramar Labs, Inc. System and apparatus for non-invasive treatment of tissue using microwave energy
US20090221999A1 (en) 2008-02-29 2009-09-03 Ramin Shahidi Thermal Ablation Design and Planning Methods
WO2009132009A1 (en) 2008-04-21 2009-10-29 Medtronic, Inc. Suction force ablation device
US7713234B2 (en) 2008-05-08 2010-05-11 Karanzas Doreen A Self-injection guide tablet
US8172835B2 (en) 2008-06-05 2012-05-08 Cutera, Inc. Subcutaneous electric field distribution system and methods
US9066738B2 (en) 2008-07-14 2015-06-30 Syneron Medical Ltd. Devices and methods for percutaneous energy delivery
US20100016782A1 (en) 2008-07-16 2010-01-21 John Erich Oblong Method of Regulating Hair Growth
CA3038950C (en) 2008-10-22 2022-08-09 Miradry, Inc. Systems, apparatus, methods, and procedures for the non-invasive treatment of tissue using microwave energy
US20110313412A1 (en) 2009-02-23 2011-12-22 Miramar Labs, Inc. Tissue interface system and method
US8394092B2 (en) * 2009-11-17 2013-03-12 Vivant Medical, Inc. Electromagnetic energy delivery devices including an energy applicator array and electrosurgical systems including same
US9050166B2 (en) * 2011-04-18 2015-06-09 Regear Life Sciences, Inc. Coupling method for resonant diathermy and other bio-tissue heating applicators
US9314301B2 (en) 2011-08-01 2016-04-19 Miramar Labs, Inc. Applicator and tissue interface module for dermatological device

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4798215A (en) * 1984-03-15 1989-01-17 Bsd Medical Corporation Hyperthermia apparatus
US6334074B1 (en) * 1997-07-31 2001-12-25 Microwave Medical Corp. Microwave applicator for therapeutic uses
US20050137662A1 (en) * 2001-02-28 2005-06-23 Rita Medical Systems, Inc. Tissue surface treatment apparatus and method

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10166072B2 (en) 2007-04-19 2019-01-01 Miradry, Inc. Systems and methods for creating an effect using microwave energy to specified tissue
US10463429B2 (en) 2007-04-19 2019-11-05 Miradry, Inc. Methods, devices, and systems for non-invasive delivery of microwave therapy
US10624696B2 (en) 2007-04-19 2020-04-21 Miradry, Inc. Systems and methods for creating an effect using microwave energy to specified tissue
US10779887B2 (en) 2007-04-19 2020-09-22 Miradry, Inc. Systems and methods for creating an effect using microwave energy to specified tissue
US11419678B2 (en) 2007-04-19 2022-08-23 Miradry, Inc. Methods, devices, and systems for non-invasive delivery of microwave therapy
US10321954B2 (en) 2011-08-01 2019-06-18 Miradry, Inc. Applicator and tissue interface module for dermatological device
US11123136B2 (en) 2011-08-01 2021-09-21 Miradry, Inc. Applicator and tissue interface module for dermatological device

Also Published As

Publication number Publication date
WO2009128940A1 (en) 2009-10-22
EP2271276A1 (en) 2011-01-12
EP2271276A4 (en) 2013-01-23
US20110040299A1 (en) 2011-02-17
US9241763B2 (en) 2016-01-26
EP2907465A1 (en) 2015-08-19

Similar Documents

Publication Publication Date Title
US9241763B2 (en) Systems, apparatus, methods and procedures for the noninvasive treatment of tissue using microwave energy
EP2762199B1 (en) Systems, apparatus, methods and procedures for the noninvasive treatment of tissue using microwave energy
US8825176B2 (en) Apparatus for the noninvasive treatment of tissue using microwave energy
EP2349167B1 (en) Systems for the non-invasive treatment of tissue using microwave energy
JP6320470B2 (en) System, apparatus method, and procedure for non-invasive tissue treatment using microwave energy
JP5827291B2 (en) System, apparatus, method and procedure for non-invasive treatment of tissue using microwave energy
JP2011517992A (en) System, apparatus, method and procedure for non-invasive treatment of tissue using microwave energy

Legal Events

Date Code Title Description
AS Assignment

Owner name: MIRAMAR LABS, INC., CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:KIM, STEVEN W.;FRANCIS, DANIEL E.;JOHNSON, JESSI ERNEST;AND OTHERS;SIGNING DATES FROM 20160126 TO 20160210;REEL/FRAME:038976/0194

AS Assignment

Owner name: OXFORD FINANCE LLC, VIRGINIA

Free format text: SECURITY INTEREST;ASSIGNOR:MIRAMAR TECHNOLOGIES, INC.;REEL/FRAME:041510/0935

Effective date: 20170307

AS Assignment

Owner name: MIDCAP FINANCIAL TRUST, AS AGENT, MARYLAND

Free format text: SECURITY INTEREST;ASSIGNORS:SIENTRA, INC.;MIRAMAR LABS, INC.;REEL/FRAME:043362/0811

Effective date: 20170725

Owner name: MIDCAP FINANCIAL TRUST, AS AGENT, MARYLAND

Free format text: SECURITY INTEREST;ASSIGNORS:SIENTRA, INC.;MIRAMAR LABS, INC.;REEL/FRAME:043361/0130

Effective date: 20170725

AS Assignment

Owner name: MIRAMAR TECHNOLOGIES, INC. F/K/A MIRAMAR LABS, INC., CALIFORNIA

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:OXFORD FINANCE LLC;REEL/FRAME:043331/0505

Effective date: 20170725

Owner name: MIRAMAR TECHNOLOGIES, INC. F/K/A MIRAMAR LABS, INC

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:OXFORD FINANCE LLC;REEL/FRAME:043331/0505

Effective date: 20170725

AS Assignment

Owner name: MIRAMAR TECHNOLOGIES, INC., CALIFORNIA

Free format text: CHANGE OF NAME;ASSIGNOR:MIRAMAR LABS, INC.;REEL/FRAME:045706/0690

Effective date: 20160602

Owner name: MIRADRY, INC., CALIFORNIA

Free format text: CHANGE OF NAME;ASSIGNOR:MIRAMAR TECHNOLOGIES, INC.;REEL/FRAME:045707/0330

Effective date: 20171228

AS Assignment

Owner name: MIDCAP FUNDING IV TRUST, SUCCESSOR AGENT, MARYLAND

Free format text: SECURITY INTEREST;ASSIGNOR:MIDCAP FUNDING X TRUST (AS SUCCESSOR TO MIDCAP FINANCIAL TRUST);REEL/FRAME:048588/0123

Effective date: 20190311

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: FINAL REJECTION MAILED

AS Assignment

Owner name: MIDCAP FINANCIAL TRUST, AS AGENT, MARYLAND

Free format text: SECURITY INTEREST;ASSIGNORS:SIENTRA, INC;MIRADRY HOLDINGS, INC.;MIRADRY, INC;AND OTHERS;REEL/FRAME:049649/0450

Effective date: 20190701

Owner name: MIDCAP FINANCIAL TRUST, AS AGENT, MARYLAND

Free format text: SECURITY INTEREST;ASSIGNORS:SIENTRA, INC;MIRADRY HOLDINGS, INC.;MIRADRY, INC;AND OTHERS;REEL/FRAME:049650/0001

Effective date: 20190701

STCV Information on status: appeal procedure

Free format text: NOTICE OF APPEAL FILED

STPP Information on status: patent application and granting procedure in general

Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION

STPP Information on status: patent application and granting procedure in general

Free format text: FINAL REJECTION MAILED

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION

AS Assignment

Owner name: MIRADRY HOLDINGS, INC., CALIFORNIA

Free format text: RELEASE OF SECURITY INTEREST (REVOLVING);ASSIGNOR:MIDCAP FUNDING IV TRUST;REEL/FRAME:056648/0001

Effective date: 20210610

Owner name: MIRADRY, INC., CALIFORNIA

Free format text: RELEASE OF SECURITY INTEREST (REVOLVING);ASSIGNOR:MIDCAP FUNDING IV TRUST;REEL/FRAME:056648/0001

Effective date: 20210610

Owner name: MIRADRY INTERNATIONAL, INC., CALIFORNIA

Free format text: RELEASE OF SECURITY INTEREST (REVOLVING);ASSIGNOR:MIDCAP FUNDING IV TRUST;REEL/FRAME:056648/0001

Effective date: 20210610

Owner name: MIRADRY HOLDINGS, INC., CALIFORNIA

Free format text: RELEASE OF SECURITY INTEREST (TERM);ASSIGNOR:MIDCAP FINANCIAL TRUST;REEL/FRAME:056648/0044

Effective date: 20210610

Owner name: MIRADRY, INC., CALIFORNIA

Free format text: RELEASE OF SECURITY INTEREST (TERM);ASSIGNOR:MIDCAP FINANCIAL TRUST;REEL/FRAME:056648/0044

Effective date: 20210610

Owner name: MIRADRY INTERNATIONAL, INC., CALIFORNIA

Free format text: RELEASE OF SECURITY INTEREST (TERM);ASSIGNOR:MIDCAP FINANCIAL TRUST;REEL/FRAME:056648/0044

Effective date: 20210610